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ABSTRACT 
 
 Myosin 10 is a vertebrate specific actin-based motor protein that is expressed in a 
variety of cell types.  Cell biological evidences suggest that myosin 10 plays a role in 
cargo transport and filopodia extension.  In order to fully appreciate these physiological 
processes, it is crucial to understand the motor property of myosin 10.  However, little is 
known about its mechanoenzymatic characteristics.  In vitro biochemical characterization 
of myosin 10 has been hindered by the low expression level of the protein in most tissues.  
In this study, we succeeded in obtaining sufficient amount of recombinant mammalian 
myosin 10 using the baculovirus expression system.  The movement directionality of the 
heterologously expressed myosin 10 was determined to be plus end-directed by the in 
vitro motility assay with polarity-marked actin filament we developed.  The result is 
consistent with the proposed physiological function of myosin 10 as a plus end-directed 
transporter inside filopodia.  The duty ratio of myosin 10 was determined to be 0.6~0.7 
by the enzyme kinetic analysis, suggesting that myosin 10 is a processive motor.  
Unexpectedly, we were unable to confirm the processive movement of dimeric myosin 
10 along actin filaments in a single molecule study.  The result does not support the 
proposed function of myosin 10 as a transporter.  One possible explanation for this 
discrepancy is that the apparent nonprocessive nature of myosin 10 is important for 
generating sufficient force required for the intrafilopodial transport by working in concert 
with numbers of other myosin 10 molecules while not interfering with each other.  
 vii 
Altogether, the present study provided qualitative and quantitative biochemical evidences 
for the better understanding of the motor property of myosin 10 and of the biological 
processes in which it is involved. 
 
 Finally, a general molecular mechanism of myosin motors behind the movement 
directionality and the processivity is discussed based on our results together with the 
currently available experimental evidences.  The validity of the widely accepted ‘lever-
arm hypothesis’ is reexamined. 
 
 viii 
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CHAPTER I 
GENERAL INTRODUCTION 
  
Molecular motors – keys to understanding how life works 
Life is maintained by biological molecules comprised of organic compounds such 
as nucleic acids, lipids, carbohydrates, and amino acids, etc.  Like machines invented by 
humans such as computers and automobiles, biological events are driven by the input of 
energy. Recent molecular biological studies have identified numerous molecular players 
that are responsible for a variety of biological processes.  In most cases, those are protein 
molecules, and many of them use energy to execute their physiological tasks.  They are 
often referred to as ‘molecular machines’, however, these machines are very unique 
compared to our artificial machines.  In general, proteins are not very solid entities.  For 
most proteins, the free energy difference between the native state and the denatured state 
is usually 2 ~10 x10-20 J (5 ~ 25 kBT), which is not so different from the thermal noise 
energy (~4 x 10-21 J ≅1 kBT) (Chen et al., 2007; Howard, 2001).  The low rigidity confers 
structural dynamics to proteins, and is important for their physiological functions.  This is 
completely different from the artificial machines, whose structural stabilities are far 
greater than the thermal noise. This may be a key to understanding the uniqueness of life.  
How do those molecular machines actually work under such conditions? 
Motor proteins such as myosin, kinesin, and dynein are good examples of 
biological molecular machines.  They carry out mechanical work using energy from ATP 
hydrolysis to control cellular structures, properly position cellular organelles, or transport 
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cellular components to specific locations in cells (Kalhammer and Bahler, 2000; Sellers, 
2000).  Dynein and myosin are essential components of flagella, cilia, and muscles, and 
their motor activities are the fundamental bases of the movement of living organisms. 
How do these molecular motors convert the chemical energy of ATP into 
mechanical work?  When compared to artificial machines such as electric devices and 
automobiles, we can easily find two very unique features of the biological molecular 
motors other than the flexibility of the structure mentioned above.  First, input energy of 
the molecular motors given by ATP hydrolysis is not very high compared to the thermal 
noise.  Although ATP is often regarded as a high energy compound, its free energy 
released by the hydrolysis under a typical physiological condition is merely ~9 x 10-20 J 
(~20 kBT), which is not so different from the thermal noise energy of ~4 x 10-21 J (~1 
kBT) (Howard, 2001).  This is contrary to the artificial machines operated by the 
significant energy input of electric voltage or gasoline explosion, which is far greater than 
the thermal noise to make the machines work precisely and quickly.  Second, energy 
conversion efficiency of the biological molecular motors is high.  The work done by 
these molecular motors is 5.6~7.9 x 10-20 J / ATP (Altman et al., 2004; Howard, 2001; 
Tanaka et al., 2002; Taniguchi et al., 2005).  Thus, the energy conversion efficiency is 
60~90 %, which is far greater than that of the latest energy efficient automobiles (~30%).  
Not only for those molecular motors, ATP is a commonly used energy source that 
drives many biological processes throughout living organisms.  Thus, understanding how 
the biological molecular motors work would eventually help us understand how life 
operates so robustly and efficiently. 
2
 Myosin motors 
Myosin is a generic term used to refer to a diverse family of molecular motors 
capable of translocating actin filaments or of transporting cargos along actin filaments by 
hydrolyzing ATP.  The myosin superfamily is comprised of 24 distinct classes of proteins 
based on sequence homology of the N-terminal motor domain (Foth et al., 2006).  The N-
terminal globular motor domain contains an ATP hydrolysis site and actin interacting 
sites, and is well conserved within the superfamily.  The crystal structures of the motor 
domains from different myosins solved so far have shown remarkable overall structural 
similarities (Coureux et al., 2004; Dominguez et al., 1998; Houdusse et al., 1999; 
Menetrey et al., 2005; Rayment et al., 1993), suggesting that myosins share the common 
molecular mechanism by which chemical energy of ATP is converted into the mechanical 
work.  The C-terminal tail portions of myosins are highly variable among the 
superfamily, implying their distinct physiological roles in a cell. 
One promising strategy for unraveling the molecular mechanism of the myosin 
motors is to compare different myosins with different motor properties to obtain 
structure–function information.  Despite the overall structural similarity of the motor 
domain within the myosin superfamily, each myosin has distinct motor properties.  Since 
the differences in motor properties are attributed to differences in the amino acid 
sequences, it is possible to identify the regions responsible for deciding the motor 
property by comparing myosins with different motor properties.  Also, since it is very 
likely that these motor properties of myosins are specifically tuned for their physiological 
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functions in cells, understanding of these motor properties of myosins can help us 
appreciate the biological processes where those myosins are involved. 
In this study, we have mainly focused on biochemical and biophysical 
characterization of class 10 myosin.  There are two main objectives for characterizing this 
myosin.  The first objective is to obtain underlying biochemical properties of myosin 10 
to explain its physiological function in a cell.  Quite a few cell biological studies have 
been done on myosin 10, however, little is known about its motor property.  The second 
objective is to obtain an additional example of the structure-function relationship of 
myosin motors to understand the molecular mechanism of myosin motors as a whole.  
Recent biochemical and biophysical characterizations of myosins from different classes 
have been beneficial for providing detailed pictures of how the unique motor property is 
determined, and characterization of yet to be analyzed myosins will contribute to a better 
understanding of how myosin motors work. 
 
Class 10 myosin 
Myosin 10 is a vertebrate-specific, ubiquitously expressed myosin (Berg et al., 
2000).  Like other myosins, the overall structure can be divided into three distinct 
regions: head, neck, and tail (Fig. II-1).  The N-terminal globular motor domain is often 
called ‘head’ because of its globular head-like structure. This domain contains ATP 
hydrolysis site and actin interaction sites, and is responsible for the motor activity.  The 
neck region is comprised of three consecutive IQ motifs (IQXXXRGXXXR) to which 
calmodulins or calmodulin-like proteins bind (Homma et al., 2001; Rogers and Strehler, 
4
2001), and thought to be a target of Ca2+-dependent regulation.  The tail region contains a 
predicted coiled-coil region, three PEST (proline-, glutamate-, serine-, and threonine-
rich) regions, three PH (pleckstrin homology) domains, a MyTH4 (myosin tail homology 
4) domain, and a FERM (band 4.1 ezrin radixin moesin) domain (Fig. II-1).  The 
predicted coiled-coil region suggests that myosin 10 can be dimerized.  The PEST 
regions are susceptible to cleavage by Ca2+-dependent protease calpain, and suggested to 
be important for protein turnover (Berg et al., 2000).  Of the three PH domains, the 
second PH domain has been reported to bind PtdIns(3,4,5)P3 (Isakoff et al., 1998; 
Mashanov et al., 2004), suggesting that myosin 10 is a downstream effector of PI(3)K 
(phosphoinositide 3-kinase).  In fact, Cox et al. recently showed that myosin 10 is 
required for Fc-mediated phagocytosis in macrophages, and its localization to the 
phagocytic cup (pseudopods of macrophages) is PI(3)K-dependent (Cox et al., 2002).  
The MyTH4 domain is found in five classes of myosins (class 4, 7, 10, 12 and 15), and 
the MyTH4 domain of Xenopus myosin 10 has recently been reported to bind to 
microtubules, which gives myosin 10 an ability to function as a motorized link between 
actin and microtubules (Weber et al., 2004).   The tail of myosin 10 ends with a FERM 
domain.  FERM domain is found in a number of cytoskeleton-associated proteins that are 
localized at the interface between the plasma membrane and the cytoskeleton.  The 
FERM domain of myosin 10 binds to the cytoplasmic domain of β1-, β3- or β5-integrin, 
suggesting that myosin 10 functions as a motorized clutch to link cell adhesion molecules 
to the actin cytoskeleton (Zhang et al., 2004). 
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One of the most interesting features of myosin 10 is its intrafilopodial motility. 
Myosin 10 localizes at the tips of filopodia (Berg and Cheney, 2002; Berg et al., 2000).  
Filopodium is a highly dynamic protrusion structure of a cell, and it has been thought to 
act as a sensor that explores the environment for growth cone guidance (Davenport et al., 
1993), angiogenesis (Gerhardt et al., 2003), and cell migration (Rorth, 2003).  Bundled 
actin filaments form the core of the filopodia with their barbed (plus) end at the tip of the 
filopodium and their pointed (minus) ends towards the cell body (Svitkina et al., 2003).  
The structural dynamics of filopodia is controlled by the balance of actin polymerization 
(at the barbed ends) and depolymerization (at the pointed ends) (Mallavarapu and 
Mitchison, 1999).  Overexpression of myosin 10 induces filopodia formation (Berg and 
Cheney, 2002), suggesting that myosin 10 has an ability to promote actin polymerization 
inside filopodia.  Tokuo et al. have recently shown that myosin 10 colocalizes with 
VASP, and moves together inside the filopodia (Tokuo and Ikebe, 2004).  VASP is an 
actin binding protein that localizes to actin stress fiber, filopodia, and the leading edge of 
lamellipodia (Bear et al., 2002).  VASP has been reported to facilitate actin 
polymerization by directly binding to the barbed (plus) end of actin and competing with 
actin capping proteins that block the actin polymerization (Bear et al., 2002).  These 
evidences strongly suggest that myosin 10 indirectly induces and maintains filopodia by 
carrying an anti-capping protein (VASP) to the barbed end tip, thereby countering to the 
continuous retraction of actin filaments.  Also, the ability of myosin 10 to bind β-
integrins makes it an attractive candidate for the formation of the adhesive structures at 
the tips of filopodia.  The tips of filopodia are recognized as specialized sites of adhesion 
6
(Tsui et al., 1985), which exert a pulling force of ~100 pN on the substrate (Bridgman et 
al., 2001). 
In addition to the role in the formation/maintenance of filopodia, myosin 10 is 
also involved in phagocytosis (Cox et al., 2002), spindle formation (Weber et al., 2004), 
nerve regrowth (Tanabe et al., 2003), axomal path finding (Zhu et al., 2007), some forms 
of acute lymphoblastic leukemia (Ross et al., 2003), and cell-cell adhesion (Yonezawa et 
al., 2003).  These findings strongly indicate that myosin 10 is a multi-functional protein.  
In this study, we particularly focused on the intrafilopodial motility of myosin 10. 
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CHAPTER II 
MOVEMENT DIRECTIONALITY OF MYOSIN 10 
 
Introduction 
 
Since actin filaments have polarity, movement directionality on actin filaments is 
one of the most important features of myosins that determines its distinct physiological 
function in a cell.  For examples, the barbed end-directed motility of muscle myosins 
(type 2 myosins) is essential for the muscle cells to contract, while the pointed end-
directed motility of myosin 6 is crucial for its role in endocytosis (Aschenbrenner et al., 
2004; Buss et al., 2001; Hasson, 2003) and for the maintenance of the stereocilia 
structure in hair cells (Frank et al., 2004; Self et al., 1999).  Myosin 10 is involved in 
intrafilopodial motility, and shows bidirectional movements inside filopodia (Berg and 
Cheney, 2002).  The speed of the rearward movement (towards the cell body) is 
approximately 10 nm/sec, which can be explained by the rate of the continuous 
retrograde flow of actin filaments in filopodia (Mallavarapu and Mitchison, 1999), 
whereas the forward movement (towards the tip) is approximately 100 nm/sec.  Since 
overexpression of myosin 10 increases the number and the length of filopodia (Berg and 
Cheney, 2002), it is likely that the forward movement is driven by myosin 10.  However, 
it is still possible that myosin 10 functions as a retrograde transport (such as dynein in 
intraflagellar transport).  In vitro biochemical study provides direct evidence for this 
issue. 
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 The motor activity of myosins is easily assessed by an in vitro motility assay in 
which we simply observe movement of fluorescently labeled actin filaments on a glass 
surface coated with myosin molecules (Kron and Spudich, 1986).  The velocity can be 
determined by analyzing the rate of actin filament movement, and the movement 
directionality can be determined if the actin filaments are polarity-marked with different 
fluorescent probes or with different fluorescence intensities.  However, the procedure for 
specifically labeling either end of actin filaments has not been established.  
Conventionally, the movement directionality of myosins was determined by the Nitella-
based in vitro motility assay (Sheetz and Spudich, 1983).  In this assay, myosin-coated 
polystyrene beads move over a fixed substratum of well-organized polar arrays of actin 
filaments derived from dissection of Nitella axillaris, a giant fresh water alga.  Although 
this assay has provided reproducible qualitative data on the movement directionalities of 
myosins (Cheney et al., 1993; Sheetz and Spudich, 1983), the system is not ideal because 
it depends on the biochemically undefined actin cables of Nitella, where unknown 
endogenous factors might affect the motor property of myosin. 
For studies of microtubule-dependent motors, a polarity-marked microtubule has 
been established with a bright seed at the minus end and a dim elongated segment only on 
the plus end (Walker et al., 1990).  The selective elongation towards the plus end is 
achieved by inclusion of NEM (N-ethylmaleimide)–treated tubulin, a competitive 
inhibitor of minus end polymerization.  Although such chemical modification that 
specifically inhibits elongation at either end of the actin filament is not known, it seems 
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possible to allow an actin filament to elongate only (or predominantly) at plus end 
because of the relatively low dissociation rate constant in the presence of ATP (Fig. II-3).  
In the current study, we developed a method to produce polarity-marked actin filament. 
An alternative protocol using gelsolin that specifically binds to the plus end of an actin 
filament has also been developed by others (Herm-Gotz et al., 2002).  These protocols 
have enabled us to determine movement directionality of myosins by performing simple 
in vitro motility assays. 
 
Materials and methods 
 
Materials - Restriction enzymes were purchased from New England Biolabs (Beverly, 
MA).  Actin was prepared from rabbit skeletal muscle. Silicone-coating reagent 
(SIGMACOTE), bovine serum albumin, pyruvate kinase, phosphoenolpyruvate, anti-
FLAG M2 affinity gel, and FLAG peptide (DYKDDDDK) were purchased from Sigma 
(St. Louis, Mo).  Phalloidin, tetramethylrhodamin-5-(or-6-)maleimide, fluorescein 
phalloidin, and Alexa Fluor 488 phalloidin were purchased from Invitrogen 
(Carlsbad,CA).  Recombinant human calmodulin was expressed in E. coli, and purified as 
described previously (Ikebe et al., 1998). 
 
Recombinant myosin 10 full-length construct - Three cDNA clones of bovine myosin 
10, i.e. clones 17 (nucleotides 1-1564), 27 (nucleotides 976-2653), and 5-2-1 (nucleotides 
2030-7769), were kindly provided by Dr. David P Corey at Harvard Medical School.  
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These clones were joined by introducing EcoRI site and XbaI site at nucleotide positions 
1240 and 2517, respectively, and the ORF region was subcloned in pFastBac vector with 
SalI site and XbaI site at 5’-side and 3’-side, respectively.  The introduction of the XbaI 
site at 2517 changed the amino acid sequence whereas the EcoRI site did not.  The XbaI 
site was fixed by site-directed mutagenesis after subcloned in the pFast vector.  The 
pFastBac vector (for baculovirus expression system) was modified to put an N-terminal 
FLAG epitope tag or an N-terminal GFP to a protein to be expressed. 
 
Recombinant calmodulin - Human testis total RNA was purchased from Clontech 
(Mountain View, CA), and cDNA library was obtained by reverse transcription with 
random oligonucleotides.  Human calmodulin ORF was subcloned in pFastBac vector 
with SpeI site and XhoI site at 5’-side and 3’-side, respectively.  For expression in E.coli, 
the ORF was subcloned in pET30 with NheI site and XhoI site at 5’-side and 3’-side, 
respectively. 
 
Baculovirus preparation - Baculoviruses used to express recombinant myosin 10 (full-
length) and recombinant calmodulin were prepared by following the instruction provided 
by Invitrogen (Carlsbad,CA). 
 
Protein expression and purification - To express the full-length recombinant myosin 10, 
Sf9 cells (approximately 2 x 108 cells) were co-infected with two viruses expressing the 
myosin 10 heavy chain and calmodulin.  The infected cells were harvested after culturing 
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for three days at 28oC, and washed with a buffer containing 150 mM NaCl, 30 mM Tris-
HCl, pH 7.5, and 5 mM EGTA.  The cells were then lysed by sonication in 10 ml of lysis 
buffer (100 mM NaCL, 50 mM Tris-HCl, pH 7.5, 2 mM MgCl2, 3 mM EGTA, 1 mM 
ATP, 1 mM phenylmethyl sulfonyl fluoride, 0.1 mg/ml trypsin inhibitor, 10 µg/ml 
leupeptin, 1 mM 2-mercaptoethanol).  After centrifugation at 300,000 ×g for 10 min at 
4oC, the supernatant was incubated with 500 µl of anti-FLAG M2 affinity gel in a 14-ml 
conical tube on a rotation wheel for 30 min at 4oC.  The resin suspension was then loaded 
on a column (1 x 10 cm) and washed with 10 ml of buffer A (150 mM NaCl, 50 mM 
Tris-HCl, pH 7.5, and 0.1 mM EGTA).  Protein was eluted with buffer A containing 0.1 
mg/ml FLAG peptide.  Freshly prepared DTT  (1 mM final concentration) was added to 
the eluted fraction, and stored on ice. 
 
Polarity-marked actin filaments - F-actin was freshly prepared according to the method 
by Spudich and Watt (Spudich and Watt, 1971).  To produce minus end seeds, F-actin 
(1.3 mg/ml) was labeled with 5-fold molar excess of tetramethylrhodamin-5-(or-
6)maleimide in the presence of 20 µM phalloidin in buffer S (25 mM KCl, 25 mM 
HEPES-KOH, pH 7.5, 5 mM MgCl2, 1 mM EGTA) in the dark at 4oC for 30 min.  The 
reaction was terminated by 10 mM DTT, and the fluorescently labeled F-actin was 
obtained by centrifugation (300,000 ×g for 7 min at 4oC).  To wash away the unbound 
fluorescent dye, the pellet was resuspended in buffer W (buffer S plus 10 µM phalloidin 
and 5 mM DTT), and pelleted again (300,000 ×g for 7 min at 4oC).  The pellet was 
homogenized and diluted with buffer W (F-actin concentration was approximately 0.03 
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mg/ml), and subjected to brief sonication.  Fragmentation of the labeled F-actin was 
visually confirmed with a fluorescence microscope.  The fragmentated F-actins serve as 
the minus end seed of the polarity-marked actin filaments. G-actin was freshly extracted 
from approximately 50 mg of rabbit back muscle acetone powder with 2 ml of buffer E (1 
mM ATP, 0.5 mM DTT, 1.5 mM CaCl2. To adjust pH at 7.5 ~ 8.0, 0.8 mM Tris-base was 
added.) on ice for 30 min.  To minimize ADP, ATP stock solution (~0.1 M) was also 
freshly prepared from powder by dissolving 18 mg of ATP in 300 µl of 150 mM Tris-
base.  The extract was then centrifuged (300,000 ×g, 10 min at 4oC), and the supernatant 
was saved.  The concentration of G-actin was determined by measuring OD at 280 nm 
(ε280 = 1.1 ml mg-1 cm-1).  The G-actin (1 µM) was added to the fluorescently labeled 
minus end seeds (~3 µg/ml) in the presence of 20 units/ml pyruvate kinase, 1 mM 
phosphoenolpyruvate, and 10 units/ml fluorescein phalloidin (or Alexa Fluor 488 
phalloidin) in buffer S.  The elongation of actin filaments was carried out overnight in the 
dark at 4oC. 
 
In vitro motility assay - A coverslip was first coated with silicon, and then coated with 
purified myosin 10.  The residual glass surface was blocked by bovine serum albumin to 
prevent polarity-marked actin filament from directly binding to the glass surface.  The 
movement of polarity-marked actin filaments was observed at 25oC in buffer S 
containing 2 mM ATP, 4.5 mg/ml glucose, 36 µg/ml catalase, 216 µg/ml glucose 
oxidase, and 143 mM 2-mercaptoethanol.  Visualization of the polarity-marked actin 
filaments was performed with an IX71 microscope platform (Olympus) with SensiCamQE 
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CCD camera (Cooke).  A dichroic mirror (51004v2bs, Chroma) and a fluorescence 
emission filter (51004v2m, Chroma) were set in the fluorescence mirror unit cassette of 
the IX71 platform, and two separate excitation filters (s555/25x and s484/15x, Chroma) 
were set in an external filter wheel unit (ProScanTM II, PRIOR scientific).  The position 
of the excitation filters was controlled by computer software (IPLab, Scanalytics), and 
two distinct sequential images were captured (One for TRITC, the other for FITC).  
Sequential images of polarity-marked actin filaments were obtained by merging the two 
sequential images from the two filters.  The movement speed of polarity-marked actin 
filaments was analyzes by collecting ≥100 data points obtained from ≥10 different actin 
filaments.  The error bar indicates the standard deviation of the data. 
 
Results 
 
Purification of recombinant myosin 10 
Although myosin 10 is ubiquitously expressed in a variety of cell types, the 
expression level of the protein is relatively low – just hundreds or a few thousand copies 
per cell (Berg et al., 2000).  To obtain sufficient amount of the protein with high purity 
required for our biochemical experiments, we decided to employ the baculovirus 
expression system with cDNA of full-length bovine myosin 10 (Fig. II-1).  This 
expression system has been used successfully in expressing a sufficient amount of 
functional myosin molecules.  (Bacteria do not express functional myosins probably due 
to the folding or the post-translational modification problem.)  The baculovirus system 
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also allows co-expression of several different proteins with different amounts.  Since 
most myosins require calmodulins or other light chains for the functions, and the 
endogenous calmodulin expressed in the host cell (sf9) is not sufficient in most cases, it is 
advantageous to be able to control the expression level of different protein components 
by simply changing the baculovirus dose. A FLAG-epitope tag was attached to the N-
terminal end of myosin 10 to facilitate the purification.  We successfully expressed and 
purified the full-length myosin 10 (Fig. II-2). Reasonable amount of calmodulin was also 
co-purified with the heavy chain that is consistent with the primary structure of myosin 
10 with three IQ motifs (Fig. II-1). 
 
Polarity-marked actin filaments 
We first prepared F-actin, and labeled it extensively at Cys-374 with 
tetramethylrhodamine maleimide.  The filament was fragmentated by brief sonication to 
make minus end nuclei of polarity-marked filaments.  Unlabeled G-actin was added at 
~1µM concentration together with comparable concentration of fluorescein phalloidin to 
label the elongated filaments.  We tested the quality of the polarity-marked filament in an 
in vitro motility assay with myosin 5a, a well-known plus end-directed myosin.  In most 
preparations, we observed many polarity-marked actins having rhodamine-labeled nuclei 
at minus end as expected.  However, in some preparations, we observed significant 
numbers of actin filaments having the rhodamine-labeled nuclei at plus end or in the 
middle of actin filaments.  This could be explained by the polymerization–
depolymerization kinetics of an actin filament (Fig. II-3).  Although the second-order 
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association rate constant of G-actin at the plus end is five times higher than that at the 
minus end in the presence of ATP, the overall affinities at plus end and minus end are not 
very different (0.2µM at plus end vs. 0.5µM at minus end).  Furthermore, in the presence 
of ADP (or when the bound ATP is hydrolyzed), the affinity becomes higher at the minus 
end (KD vales are 6 µM at plus end and 2 µM at minus end).  In any case, the possibility 
of generating false-polarity-marked actin filaments impairs the accuracy of directionality 
determination of myosins with unknown movement directionality. 
In order to minimize falsely marked actin filaments, we paid particular attention 
to the following points in developing an improved method.  First, ADP-bound G-actin 
has lower affinity towards the plus end (6µM) than that towards the minus end (2µM).  
Thus, the use of stored (frozen) G-actin was avoided because the bound ATP will be 
hydrolyzed during storage.  Second, Ca2+ATP-bound G-actin has a high critical 
concentration (100 ~ 200µM), and Mg2+/Ca2+ exchange rate is very low.  Thus, if G-actin 
is prepared in the presence of Ca2+ATP instead of Mg2+ATP, and Mg2+ is added only 
when polymerization takes place, we should be able to facilitate actin filament elongation 
predominantly at the plus end by minimizing the actual concentration of Mg2+ATP-bound 
G-actin in the polymerization solution.  Third, ATP regeneration would also increase the 
probability of actin filament elongation only at the plus end by minimizing the population 
of ADP-bound G-actin.  A new protocol is established based on these considerations, and 
is described in ‘Materials and Methods’ in more detail.  The polarity-marked actin 
filament produced by this method is phenomenal.  Almost all double-stained actin 
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filaments have their rhodamine-labeled seeds properly positioned at the minus end.  
(Appendix A). 
 
Movement directionality of full-length myosin 10  
By using the polarity-marked actin filaments, we performed in vitro motility assay 
on the full-length myosin 10.  Polarity-marked actin filaments moved with the 
rhodamine-labeled minus end leading the movement, which unambiguously demonstrates 
that myosin 10 is a plus end-directed motor (Fig. II-4).  The conclusion is consistent with 
the proposed physiological role of myosin 10 as a transporter in filopodia, which carries 
VASP to the tip to facilitate filopodia elongation or maintenance by opposing the 
continuous retraction of actin filaments.  In addition, the speed of actin filament 
translocation observed in the in vitro motility assay (0.12 ± 0.04 µm/sec) was consistent 
with the speed of plus end-directed movement of GFP-labeled myosin 10 observed in a 
living cell (~0.1 µm/sec).  Since myosin 10 has to counteract the continuous retraction of 
actin cables (~0.01 µm/sec), it is reasonable that the speed observed in vitro was slightly 
faster than that observed in filopodia in a living cell. 
 
Effect of Calmodulin-like protein on the movement directionality of myosin 10 
In addition to calmodulin, calmodulin-like protein (CLP) has been reported to 
bind to the third IQ domain of myosin 10 (Rogers and Strehler, 2001).  CLP retains ~85% 
amino acid sequence homology to calmodulin, and is only expressed in the epithelial 
cells.  Since the expression of myosin 10 is ubiquitous, CLP does not seem to be the 
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universal light chain of myosin 10.  However, it is possible that the binding of CLP may 
affect the movement directionality of myosin 10.  To test this possibility, we co-infected 
Sf9 cells with full-length myosin 10 heavy chain expressing virus, calmodulin expressing 
virus, and CLP expressing virus.  The expressed myosin 10 heavy chain was co-purified 
with calmodulin and CLP (Fig. II-5).  To ensure complete binding of CLP to the heavy 
chain, the in vitro motility assay was performed with excess amount of exogenous CLP 
(1 mg/ml).  As expected, the plus end-directed motility was not affected by the binding of 
CLP. 
 
Effect of N-terminal GFP-tag and truncation on the directionality 
Several cell biological studies have been done using myosin 10 constructs with N-
terminal GFP tag (Berg and Cheney, 2002; Bohil et al., 2006; Tokuo and Ikebe, 2004; 
Zhang et al., 2004).  We also generated several myosin 10 constructs with N-terminal 
GFP tag for the single molecule experiment described in Chapter IV.  For enzyme 
kinetics study described in Chapter III, we used truncated myosin 10 construct that 
contains the motor domain and the first IQ motif (M10IQ1).  Although N-terminal GFP-
tagged myosin constructs and truncated myosin constructs have been widely used for 
myosin research, those modifications might affect the inherent movement directionality 
of myosin 10.  Therefore, we checked the movement directionalities of the GFP-tagged 
full-length myosin 10 construct and the truncated myosin 10 construct (M10IQ1).  Both 
of them showed plus end-directed motility with similar actin translocating velocities as 
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observed for full-length myosin 10 (Table II-1), suggesting that the directionality is not 
affected by the N-terminal GFP or the truncation at the neck region. 
 
Discussion 
 
Implication of the plus end directionality of myosin 10 in intrafilopodial motility 
 We succeeded in expressing and purifying the full-length mammalian myosin 10 
using the baculovirus system.  Using the recombinant myosin 10, the movement 
directionality was unambiguously determined to be plus end-directed by the in vitro 
motility assay using the polarity-marked actin filaments we developed.  The directionality 
is consistent with the proposed physiological role of myosin 10 as a plus end-directed 
cargo transporter.  The actin translocating velocity determined by the in vitro motility 
assay is also consistent with the velocity of myosin 10 observed in filopodia of living 
cells.  The retrograde movement of myosin 10 towards the cell body can be reasonably 
explained by the rate of the continuous retrograde flow of actin filaments in filopodia 
(Mallavarapu and Mitchison, 1999).  It is possible that myosin 10 takes advantage of the 
retrograde flow of the actin filament to recycle itself for another round of transport. 
 
Implication of processivity 
Processivity is the ability of a myosin molecule to successively move along actin 
track for a long distance without dissociating from the track, and it is thought that a 
processive myosin motor is suitable for cargo transport.  The processivity of myosin 10 
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inferred from the observation in the in vitro motility assay is discussed, although the 
processivity of myosin 10 is vigorously tested in Chapter IV 
Methylcellulose is sometimes added to the buffer solution for in vitro motility 
assay.  This highly elongated polymer prevents actin filaments from diffusing in a 
direction perpendicular to the long axis.  Thus, inclusion of methylcellulose (~0.5%) in 
the motility assay buffer greatly aids actin translocation by highly nonprocessive myosins 
or myosins at very low density on the glass surface, by simply slowing down the 
diffusion of actin filaments away from the glass surface during brief moments when no 
myosin molecule is bound to actin.  In our experience, for highly processive myosins 
such as myosin 5a, methylcellulose is not necessary because at least one of the two heads 
of a myosin 5a molecule (double-head structure) holds actin filament due to its highly 
processive nature.  For nonprocessive myosins such as smooth muscle myosins, however, 
we always needed to add methylcellulose to the assay buffer even if the loading 
concentration of myosin was very high (~2µM).  In the case of myosin 10, we were able 
to visualize movement of actin filaments easily without adding methylcellulose despite 
the relatively low loading concentration (typically < 0.4 µM), suggesting that myosin 10 
is processive, or at least more processive than smooth muscle myosin.  The relatively 
high processivity of myosin 10 was actually confirmed by performing motor density 
dependent in vitro motility assay where 0.5% methylcellulose was used to successfully 
observe the actin translocations by smooth muscle myosin (Fig. II-6).  It should be noted 
that this experiment merely shows relative degree of processivity, rather than the actual 
processivity.  Also, since faster actin translocating velocities tend to be obtained on 
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myosin 10 with methylcellulose, the velocity of myosin 10 determined in this experiment 
will not be discussed. 
Another indication of processivity is severing of actin filaments observed in the in 
vitro motility assay.  In the case of processive myosins, simultaneous interaction of 
numerous myosin heads to actin filaments causes severing of the filaments, and this is 
conspicuous for myosin 5a at a loading concentration of ~0.5 µM.  We have not seen 
severing of actin filaments for smooth muscle myosin at a high loading concentration 
(2~4 µM) with methylcellulose.  For myosin 10, we observed severing of actin filaments 
during the in vitro motility assay at a loading concentration of ~0.4 µM, suggesting again 
that myosin 10 is a processive motor.   
 
Other findings 
Nitrocellulose-coated coverslip is usually used for in vitro motility assay of 
myosins, however, for the myosin 10 full-length construct, silicone-coated coverslips 
were used because full-length myosin 10 did not seem to bind to the nitrocellulose-coated 
glass surface.  Because the silicone coating provides a hydrophobic surface on the 
coverslip, the result may suggest a hydrophobic nature of the C-terminal tail of myosin 
10.  This may induce clustering of molecules through hydrophobic interaction, and might 
be important for the stable dimer formation because the predicted coiled-coil region of 
myosin 10 does not form stable coiled-coil (Knight et al., 2005).  However, at least we 
did not see any sign of the clustering in our single molecule experiments described in 
Chapter IV. 
21
 22
  
 
 
Figure II-1. Schematic representation of myosin 10. CC, the predicted coiled-coil; 
PEST, proline-, glutamate-, serine-, and threonine-rich region; PH, pleckstrin homology 
domain; MyTH4, myosin tail homology 4 domain; FERM, band 4.1 ezrin radixin moesin 
domain. 
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Figure II-2. Expression and purification of myosin 10 full-length construct. The 
sample of each purification step was examined by SDS-PAGE and stained with 
Coomassie Brilliant Blue. Lane 1, total cell lysate; Lane 2, 300,000 × g supernatant; Lane 
3, 300,000 × g pellet; Lane 4, unbound fraction from the FLAG M2 affinity gel; Lane 5-
7, elutes from the affinity column with 0.1mg/ml FLAG peptide. HC, heavy chain of 
myosin 10 full-length; CaM, calmodulin. 
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Figure II-3. Assembly and disassembly of actin. 
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Figure II-4. Ensemble in vitro surface assay with polarity-marked actin. A, 
Schematic representation of the polarity-marked actin filament. B, Sequential images of 
the movement of polarity-marked actin filaments by myosin 10 full-length construct.  C, 
Histogram of the velocity of the actin filaments driven by myosin 10. 
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Figure II-5. Copurification of calmodulin-like protein with the heavy chain of full-
length myosin 10.  The eluate from the FLAG affinity column was analyzed by SDS-
PAGE and stained with Coomassie Brilliant Blue.  HC, heavy chain; CaM, calmodulin; 
CLP, calmodulin-like protein. 
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Figure II-6. Actin filament velocity as a function of myosin surface density. The 
surface density was calculated by the myosin concentration times the flow cell volume 
divided by the area of both flow cell faces, assuming all the myosins molecules added 
were attached on the glass surface. This would provide the upper limit of the number of 
molecules per unit area. Unlike all the other in vitro motility assays described throughout 
this thesis, 0.5% methylcellulose was used. ●, myosin 5a heavy meromyosin; ■, smooth 
muscle myosin (phosphorylated); ▲, myosin 10 (truncated at the end of the predicted 
coiled-coil region). 
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CHAPTER III 
THE DUTY RATIO OF MYOSIN 10 
 
Introduction 
 
Myosins translocate (or move along) actin filaments by hydrolyzing the common 
energy source, ATP, and by releasing the common reaction products, ADP and phosphate 
(Pi).  However, the detailed enzyme kinetic mechanism of the ATPase reaction is 
different among the members of the myosin superfamily, and the characteristic ATPase 
reaction mechanism determines the duty ratio – a quantitative indicator that is thought to 
be closely related to the processivity of myosin motors.  Processivity, together with the 
movement directionality, determines the distinct physiological functions of individual 
myosin motors in a cell.  The term “processivity” is defined as the ability of an enzyme to 
repetitively continue its catalytic function without dissociating from its substrate.  In the 
case of myosin motors, the processivity is defined as the ability to repetitively translocate 
an actin filament without dissociating from the actin filament.  It is called nonprocessive 
if a myosin motor translocates an actin filament only once per diffusional encounter with 
the filament. 
The duty ratio of myosin is defined as the fraction of the time that a motor domain 
spends attached to an actin filament during an ATPase cycle.  Myosins with high duty 
ratios can maintain continuous attachment to an actin filament and can move along the 
filament on their own (thus processive), whereas myosins with low duty ratios usually 
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oligomerize into a large assembly in order to produce continuous motility (the individual 
molecules are nonprocessive).  Myosin 5a is the best-characterized processive myosin 
with a very high duty ratio (>0.7).  The molecule has a double-headed structure 
(homodimer) (Cheney et al., 1993), and moves along actin filaments preocessively by 
hand-over-hand mechanism (Warshaw et al., 2005; Yildiz et al., 2003).  For the 
processive movement by hand-over-hand mechanism, at least one of the two heads (the 
lead head) has to stay on an actin filament until the other head (the trail head) binds to the 
forward binding site on the actin filament.  Thus the duty ratio of >0.5 is a prerequisite 
for making a double-headed myosin molecule processive by hand-over-hand mechanism 
as seen in myosin 5a.  Muscle myosins such as skeletal muscle myosins are typical low 
duty ratio motors.  Although these myosins have double-headed structure, they do not 
move processively along actin filaments by themselves due to their extremely low duty 
ratios (0.01~0.02).  Muscle myosins form thick filaments, and together with actin 
filament, they form a lattice structure called sarcomere where numerous myosin heads 
simultaneously interact with actin filaments to produce quick movement and force as a 
whole.  In this circumstance, it is advantageous to have a low duty ratio so that the 
binding of one head does not interfere with the translocations of actin by other heads.  
Thus, the very low duty ratio of muscle myosins is important for the physiological 
functions of muscles.  By knowing the duty ratio, we can estimate the degree of 
processivity of a myosin molecule, and therefore, we can infer the physiological process 
where the myosin molecule is involved. 
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In this chapter, the duty ratio of myosin 10 is determined by performing transient 
enzyme kinetics. 
 
Materials and methods 
 
Materials - Nickel-nitrilotriacetic acid agarose (Ni-NTA) was purchased from Qiagen 
(Hilden, Germany).  (2’-(or-3’)-O-(N-methylanthraniloyl)adenosine 5’-triphosphate 
(mant-ATP) and (2’-(or-3’)-O-(N-methylanthraniloyl)adenosine 5’-diphosphate (mant-
ADP) were purchased from Invitrogen (Carlsbad,CA).  Purine nucleoside phosphorylase 
(PNPase), 7-methylguanosine (MEG), phosphoenolpyruvate and pyruvate kinase were 
obtained from Sigma (St. Louis, MO).  Pyrene-actin was prepared as previously 
described (Kouyama and Mihashi, 1981).  7-diethylamino-3-((((2-
maleimidyl)ethyl)amino)carbonyl)coumarin-labeled phosphate binding protein (MDCC-
PBP) was prepared as described (Brune et al., 1994; White et al., 1997). For other 
materials, see “Materials and methods” in Chapter II. 
 
Recombinant truncated myosin 10 construct - A partial ORF of bovine myosin 10 (Met 
1 – Gln 773) with the hexahistidine tag sequence at the 3’-end was subcloned in pFastBac 
vector (for baculovirus expression system) with KpnI sites.  This construct is named 
M10IQ1. 
 
Baculovirus preparation - See “Materials and methods” in Chapter II. 
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 Protein expression and purification - To express the recombinant myosin 10 (M10IQ1), 
Sf9 cells (approximately 4 x 108 cells) were co-infected with two viruses expressing the 
M10IQ1 heavy chain and calmodulin.  Infected cells were harvested after culturing for 
three days at 28oC, and washed with a buffer containing 150 mM NaCl, 30 mM Tris-HCl, 
pH 7.5, and 5 mM EGTA.  The cells were then lysed by sonication in 20 ml of lysis 
buffer (25 mM KCl, 30 mM HEPES-KOH, pH 7.5, 2 mM MgCl2, 0.2 mM EGTA, 1 mM 
ATP, 1 mM phenylmethyl sulfonyl fluoride, 0.1 mg/ml trypsin inhibitor, 10 µg/ml 
leupeptin, 1 mM 2-mercaptoethanol).  After centrifugation at 300,000 ×g for 10 min at 
4oC, the supernatant was incubated with 300 µl of Ni-NTA resin in a 14-ml plastic tube 
on a rotation wheel for 10 min at 4oC.  The resin suspension was then loaded on a column 
(1 x 10 cm) and washed with 10 ml of wash buffer (50 mM KCl, 20 mM HEPES-
KOH/10 mM Imidazole-HCl, pH 7.5, 0.1 mM EGTA, 5 µg/ml leupeptin, and 1 mM 2-
mercaptoethanol).  M10IQ1 was eluted with the wash buffer containing 200 mM 
Imidazole-HCl, pH 7.5. The purified M10IQ1 was dialyzed against a dialysis buffer B 
(25 mM KCl, 25 mM HEPES-KOH (pH 7.5), 5 mM MgCl2, 1 mM EGTA).  The protein 
was stored on ice and used within 2 days.  Typically, 1~1.5 mg of M10IQ1/CaM was 
obtained.  Protein concentration was determined by Bradford method using BSA as a 
control and corrected by the purity of the sample determined by densitometry analysis, 
assuming degradation of the protein is negligible.   [2,8-3H]ADP/VO4 was used to 
determine the concentration of active M10IQ1.  The active motor concentration was 
typically 70~80% of that estimated by the Bradford method. This is primarily due to the 
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overestimation of the M10IQ1 concentration using BSA as a control, and also minor 
fraction of nonfunctional M10IQ1 during the purification. 
 
ATPase assay - The steady-state ATPase activity of M10IQ1 was measured at 25°C in 
the presence of 2 mM ATP with an ATP regeneration system (40 units/ml pyruvate 
kinase and 2 mM phosphoenolpyruvate).  The reaction was carried out in buffer B with 
0.2 mg/ml calmodulin at 25oC.  The liberated pyruvate was determined as described 
(Reynard et al., 1961).  Error bars show standard error from three different preparations. 
 
Polarity-marked actin filaments - See “Materials and methods” in Chapter II. 
 
In vitro motility assay - See “Materials and methods” in Chapter II. 
 
Actin-cosedimentation assay - The binding of M10IQ1 with actin in the presence of 
ADP was determined using 1 µM M10IQ1 and 5 µM F-actin in buffer B with 0.2 mg/ml 
calmodulin and 0.1 mM ADP, and centrifuged at 300,000xg at 25oC for 10min.  The 
pellet was dissolved with 8 M urea, and both supernatant and the pellet were analyzed by 
an SDS-PAGE with Coomassie Brilliant Blue staining. 
 
Quenched-flow measurement - Quenched-flow measurement was performed in buffer B 
ith 0.2 mg/ml calmodulin at 25oC by a KinTek RQF-3 apparatus (KinTek Co., Clarence, 
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PA) (Kambara et al., 1999).  Error bars show standard error from three independent 
experiments. 
 
Stopped-flow experiments - Kinetic measurements were performed in buffer B with 0.2 
mg/ml calmodulin at 25°C using a KinTek SF-2001 apparatus (KinTek Co., Clarence, 
PA) with a 75-watt xenon lamp.  Mant-nucleotides were excited at 360 nm and the 
fluorescence was monitored using a 420 nm cut-off filter.  Pyrene-actin was excited at 
365 nm with a 365nm band-pass filter and the fluorescence was monitored using a 400 
nm cut-off filter.  Intrinsic tryptophan residues in M10IQ1 were excited at 295 nm and 
the fluorescence was monitored using 340 nm cut-off filter. MDCC-PBP was excited at 
436 nm with 436 nm band pass filter and the fluorescence was monitored using 450 nm 
cut-off filter.  3 µM MDCC-PBP, 0.01 units/ml PNPase and 0.3 mM MEG were included 
in all solutions.  Light scattering at 550 nm was observed to monitor dissociation of acto-
M10IQ1.  The volume ratio of the syringe was 1:1 in all single mixing experiments, and 
1:1:1 in double mixing experiments.  Curve fitting was done using the KinTek SF-2001 
software.  Error represents standard error from 3-10 independent experiments. 
 
Computer simulation - Kinetic simulations were performed using STELLA v8.1.1 
software (iseesystems, Lebanon, NH).  See Appendix D. 
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Results 
 
The truncated recombinant myosin 10 construct (M10IQ1) 
The myosin 10 construct (M10IQ1) employed in this study contains the motor 
domain and the first IQ domain (Met1-Gln773) followed by hexahistidine tag to facilitate 
purification.  This truncated single-headed construct was used in the present study to 
avoid the possible complexity arising from the formation of an oligomeric structure.  The 
M10IQ1 was expressed using the baculovirus expression system together with 
calmodulin in Sf9 cells and purified with Ni2+-agarose affinity column.   As expected 
from the design of the construct, the isolated protein had an apparent molecular mass of 
90 kDa co-purified with a low molecular mass protein (Fig. III-1A).  The mobility of the 
low molecular mass peptide on an SDS-PAGE increased with Ca2+, suggesting that it is 
calmodulin (data not shown).  The amount of bound calmodulin to M10IQ1 seemed to be 
low, likely due to the partial loss of the bound calmodulin during the purification steps.  
We observed that the actin-activated ATPase of M10IQ1 increased upon addition of 
calmodulin, suggesting that the IQ domain of the purified M10IQ1 is not completely 
occupied with calmodulin (Fig. III-2).  Based on this result, the apparent dissociation 
constants of calmodulin for M10IQ1 were estimated to be 2.7 ± 1.2 µg/ml and 1.4 ± 0.2 
µg/ml, in the presence (0.1 mM) and the absence of Ca2+, respectively.  Therefore, we 
added 0.2 mg/ml calmodulin to the M10IQ1 sample in all experiments in this study. 
Calmodulin-like protein (CLP) has been reported to preferentially bind to the third IQ 
motif of myosin 10 in the presence of Ca2+ (Rogers and Strehler, 2001).  Although it is 
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less likely that CLP binds to the first IQ motif of the M10IQ1 construct in our 
experimental condition (EGTA condition), we tested if CLP is co-purified with the 
M10IQ1 heavy chain.  Despite the high expression level of CLP in Sf9 cell that was 
comparable to that of calmodulin, the co-expressed CLP was not co-purified with 
M10IQ1 (data not shown).  The result is consistent with a previous report (Rogers and 
Strehler, 2001), and suggests that the affinity of CLP to the first IQ motif is very low in 
the absence of Ca2+.  Therefore, for the enzyme kinetics experiments, we focused on 
M10IQ1 having only calmodulin as the light chain. 
Figure III-1B shows the actin-activated ATPase activity of M10IQ1 as a function 
of the actin concentration.  The ATPase activities at various actin concentrations were 
fitted well with a Michaelis–Menten equation to yield Vmax and KATPase of 13.5 ± 1.6 s-1 
and 17.4 ± 5.2 µM, respectively.  We also performed an in vitro motility assay on the 
M10IQ1 construct to see if the M10IQ1 retains the actin translocating activity.  The 
velocity was 0.17 ± 0.03 µm/sec (Table III-1 and Fig. III-1C).  The movement 
directionality was determined to be plus end-directed using the polarity-marked actin 
filament used in Chapter II (Table II-1).  The results suggest that the C-terminal 
truncation at the neck does not impair the motor function of myosin 10.  We also found 
that the addition of exogenous calmodulin  (> 0.05 mg/ml) greatly increased the fraction 
of actin filament moving in the in vitro motility assay, suggesting that the binding of light 
chain to the IQ domain is essential for the motor function of myosin 10, and that the 
affinity of calmodulin to the first IQ domain is relatively low.  This is consistent with the 
result of calmodulin dependent ATPase assay (Fig. III-2). 
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 ATP binding to M10IQ1 and acto-M10IQ1 
The initial step of the ATP binding is a diffusion-limited process with an 
association constant K1 or K’1 (Appendix C).  After the formation of the collision 
complex ((MT) or (AMT)), the motor domain weakly binds to actin (weakly actin-bound 
state) with a rate constant k+2 or k’+2.  Figure III-3 shows the rate of mant-ATP binding to 
M10IQ1 as a function of mant-ATP concentration.  The fluorescence intensity is 
sensitive to its environment (either hydrophilic or hydrophobic), and increases when the 
fluorophore is trapped in the active site of myosin and forms MT or AMT complex.  Thus 
the apparent ATP biding rates become K1k+2 or K’1k’+2 (Appendix C).  The increase in 
the fluorescence intensity of mant-ATP followed single exponential kinetics for both 
M10IQ1 and acto-M10IQ1 (Fig. III-3, insets).  The observed rate constants linearly 
increased with mant-ATP concentration to yield second order rate constants of 3.4 ± 0.3 
µM-1s-1 and 4.7 ± 0.2 µM-1s-1 for acto-M10IQ1 and M10IQ1, respectively.  The 
extrapolation of the straight lines intercepts y-axis at < 2 s-1, suggesting that the rate for 
the reverse reaction (k-2 and k’-2) of the ATP binding step is < 2 s-1.   
 
ATP-induced population of weakly bound acto-M10IQ1 
A disadvantage of using mant-ATP is the high background fluorescence when 
used at high concentrations (this is also the case for other fluorescent substrates).  
Theoretically, k+2 or k’+2 can be determined from the maximal rates attained at saturating 
concentration of the substrate, however, the signal-to-noise ratio quickly plummets with 
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higher substrate concentrations, and the analysis usually collapses before even seeing a 
sign of curvature.  Furthermore, mant-ATP may not properly represent regular ATP for a 
particular myosin, though mant-ATP has been used in many enzyme kinetics studies.  An 
alternative way of monitoring the ATP binding and the formation of the actin weakly-
bound state is to monitor the change in fluorescence of pyrene-labeled actin upon 
addition of ATP (myosin is premixed with the pyrene-labeled actin).  Although the rates 
in the absence of actin cannot be determined by this method, we can determine K’1k’+2, 
k’+2, and k’-2 by using regular ATP.  The fluorescence intensity of pyrene increases upon 
formation of the weakly actin-bound complex (AMT) or dissociation of the motor 
domain from the pyrene actin, thus we can monitor the formation of AMT by simply 
following the pyrene fluorescence.  Rapid mixing of ATP to pyrene-acto-M10IQ1 
resulted in an increment of pyrene fluorescence as is observed for other unconventional 
myosins (De La Cruz et al., 2001; De La Cruz et al., 1999; El Mezgueldi et al., 2002).  
The time course of the observed fluorescence transient was best fitted to a single 
exponential kinetics (Fig. III-4, inset) and the apparent rate constants at various ATP 
concentrations showed a hyperbolic relationship against ATP concentration as expected 
(Fig. III-4).  The binding rate constant of ATP to acto-M10IQ1 (K’1k’+2) can be obtained 
from the initial slope.  The value (2.7 ± 0.4 µM-1s-1) was consistent with that obtained by 
using mant-ATP (Fig. III-3).  The maximum rate constant estimated from the hyperbolic 
curve fitting (k’+2) was 782 ± 74 s-1, which was more than 50-fold larger than the Vmax of 
the steady state ATPase activity of acto-M10IQ1.  Therefore, the ATP binding step and 
the following isomerization step (k’+2) are not rate limiting for acto-M10IQ1 ATPase 
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cycle under physiological ATP concentrations (1~2 mM). 
 
Dissociation of acto-M10IQ1 by ATP 
The dissociation of acto-M10IQ1 was monitored by measuring the decrease in 
light scattering intensity upon mixing acto-M10IQ1 with ATP (Fig. III-4). The time 
course of the signal change was fitted with a single exponential kinetics (Fig. III-4, inset) 
and the apparent rate constants of acto-M10IQ1 dissociation were hyperbolically 
increased with ATP concentration to yield the maximum value of 885 ± 36 s-1.  The 
hyperbola was almost identical to that obtained from the change in pyrene fluorescence 
intensity, suggesting that the dissociation of acto-M10IQ1 (k+8, k-8 pathway) is a rapid 
process. 
 
ATP hydrolysis monitored by tryptophan fluorescence 
The motor domain of myosin 10 contains a conserved tryptophan residue (W481) 
located at the rigid relay loop.  This residue is equivalent to W510 of skeletal muscle 
myosin 2 that has been shown to be the largest contributor to the enhancement of the 
intrinsic tryptophan fluorescence associated with ATP binding and hydrolysis.  The 
intrinsic tryptophan fluorescence intensity of M10IQ1 increased upon addition of ATP 
and the increase followed single exponential kinetics (Fig. III-5, inset).  The apparent rate 
constants increased with ATP to show a hyperbolic dependence (Fig. III-5) and yielded a 
maximum rate constant of 395 ± 26 s-1.  The ATP binding rate constant obtained from the 
initial tangent of the hyperbola was 4.4 ± 0.6 µM-1s-1, which was consistent with the 
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value obtained from mant-ATP binding experiment (Fig. III-3).  We assume that the 
intrinsic tryptophan fluorescence enhancement of M10IQ1 by ATP monitors 
predominantly the hydrolysis step (k+3 + k-3, Appendix C), because the observed maximal 
rate constant of 300~400 s-1 was less than half of that of the maximal ATP binding rate 
(k’+2 ~800 s-1) determined by ATP induced pyrene fluorescence change.   Since the ATP 
binding rate constant in the absence of actin is even greater than that in the presence of 
actin (suggesting k+2 > k’+2 if K1= ~K’1), if the intrinsic tryptophan fluorescece 
enhancement predominantly monitors the ATP binding but not the following hydrolysis 
step, the maximal rate should be k+2 which should be similar to or larger than k’+2 (~800 
s-1). 
 
ATP hydrolysis directly measured by quenched-flow 
The motor domain of a myosin forms a myosin/ADP/P ternary complex (MDP) 
after ATP hydrolysis.  Since the protein bound phosphate is released from myosin by acid 
quenching of the ATPase reaction, rapid initial phosphate release is observed when the 
reaction is stopped by acid (Pi burst).  Figure III-6 shows the time course of Pi release of 
M10IQ1 ATPase reaction measured by a quenched flow experiment.  Single turnover 
experiment was carried out to determine the equilibrium of the hydrolysis step (Fig. III-
6A).  1µM of [γ−32P]ATP was mixed with 2 µM M10IQ1 so that all given ATP was 
bound to the ATP binding site of myosin 10.   Pi was rapidly released from acto-M10IQ1 
followed by slow Pi release.   The fast phase represents the initial rapid ATP hydrolysis 
by M10IQ1.  The slow phase (0.06 s-1) corresponds to the apparent Pi release rate (k+4 
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obs). The presence of the slow Pi release phase suggests that a certain population of 
M10IQ1 is present as a prehydrolysis step (MT).  From the ratio of the fraction of the fast 
phase to the slow phase, the Pi burst size of 0.46 ± 0.02 was obtained.   The result 
indicates that the equilibrium of MT–MDP step is significantly shifted to the pre-
hydrolyzed form.  The rate of the ATP hydrolysis was also measured with higher ATP 
concentrations (Fig. III-6B).  The initial Pi-burst rates were 65 s-1 and 124 s-1 in the 
presence of 10.7 µM ATP and 20.9 µM ATP, respectively.  The observed rate constants 
were limited by ATP binding rate at a given ATP concentration, suggesting that the ATP 
hydrolysis rate (k+3 + k-3) is greater than 120 s-1. 
 
Phosphate release rate 
Fluorescently labeled phosphate binding protein (MDCC-PBP) was used to 
monitor the rate of phosphate release in the presence and absence of actin (Fig. III-7).  
The fluorescence increased upon binding of released phosphate and it followed a single 
exponential kinetics in the absence of actin.  The observed rate, 0.06 ± 0.02 s-1 (k+4 obs), 
was consistent with the rate obtained from the quenched-flow experiment (Fig. III-6A).  
In the presence of actin, however, the fluorescence increment followed double 
exponential kinetics as reported recently (Kovacs et al., 2005).  The fast phase was actin 
concentration dependent as expected from the kinetics scheme (scheme III-1).  We could 
not see any sign of curvature within the experimentally achievable actin range tested.  
The slope gives us a second order rate constant for MDP–AMDP transition (k’+4/K9 obs, 
Appendix C), and it was 0.71 ± 0.02 µM-1s-1 (Fig. III-7B).   The maximum Pi release rate 
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in the presence of actin was estimated to be >100 s-1 based upon the lack of curvature up 
to 50µM actin.  The slow phase was actin independent and fairly constant throughout the 
actin concentrations tested.  The slow phase is not an artifact coming from the MDCC-
PBP system, because we did not observe the dual phase on skeletal myosin S-1.  One 
possible explanation for the slow phase is due to the ‘attached hydrolysis (AMT–
AMDP)’ as reported (Kovacs et al., 2005; White et al., 1997).  The other possibility is the 
ATP rebinding to M10IQ1 during the observation.  In principle, these two possibilities 
can be discriminated by performing the experiment with different M10IQ1 
concentrations.  The rate of the slow phase is independent of M10IQ1 concentration if the 
former situation is the case.  On the other hand, if the latter situation is the case, the rate 
of ATP rebinding is expected to be faster at higher M10IQ1 concentration, thus we 
should see faster second phase.  We performed the same experiment as in Fig. III-7A as a 
function of M10IQ1 concentration from 0.25 to 0.67µM (in final), with fixed actin 
concentration (5µM in final) and ATP concentration (0.23µM in final) (Fig. III-7B, 
inset).  The rate of the slow phase increased by increasing the M10IQ1 concentration 
while the fast phase remained at the same rate ~5.5 s-1, suggesting the slow phase came 
from the ATP rebinding during the observation.  With given ATP concentration (0.23 
µM), the rate constant of the forward reaction is ~1 s-1. The rate constant of ~1 s-1 for the 
reverse reaction (that is possible with k-2 = 0.2 ± 1.3, Fig. III-3) together with the 
equilibrium of ATP hydrolysis step (K3 = 0.85), explains the observed ~40% contribution 
of the slow phase to the total phase (Fig. III-7A, inset). We think that the attached 
hydrolysis (AMT–AMDP) is negligible under the condition we used in this study (see 
42
Discussion).  We conclude that the phosphate release (> 100 s-1) is not the rate-limiting 
step of acto-M10IQ1 ATPase cycle.  We assume k-4 and k’-4 as ~0 s-1, because mM 
concentrations of phosphate had little effect on the ATPase activity of M10IQ1 (Fig. III-
8). 
 
Kinetics of ADP binding and dissociation 
The rate of ADP binding to acto-M10IQ1 was measured by monitoring the 
change in the fluorescence intensity of mant-ADP upon binding.  In the absence of actin, 
the rate of mant-ADP binding showed a hyperbolic dependence on the mant-ADP 
concentration to yield the maximum rate of 1.11 ± 0.07 s-1 (Fig. III-9A).  This result 
suggested that ADP binding is a two-step process as for the ATP binding.  The first step 
is the formation of a collision complex and the second one is the conformational 
transition (Appendix C).  The observed maximum rate constant represents the sum of the 
forward and backward steps, i.e., k5 + k-5, of the second step.  The y-intercept of the 
mant-ADP dependence gave 0.28 ± 0.06 s-1, suggesting that the rate constant of mant-
ADP release is 0.28 s-1.   The mant-ADP release rate was directly determined by 
measuring the decrease in mant-ADP fluorescence intensity upon addition of 3 mM ATP 
to M10IQ1/mant-ADP (Fig. III-9B).  The rate constant of 0.27 s-1 was obtained that is 
consistent with the value obtained from Fig. III-9A. The affinity of ADP for M10IQ1 
(K5K6) was calculated to be 1.2 µM. 
In the presence of actin, the mant-ADP binding rate increased with the mant-ADP 
concentration to yield the second order rate constant of 2.6 ± 1.3 µM-1s-1. The 
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dissociation rate constant of 17 ± 3.6 s-1 was obtained by extrapolation of the binding rate 
to zero mant-ADP concentration (Fig. III-10A).  The rate of ADP dissociation was also 
directly measured by mixing acto-M10IQ1/ADP complex with excess ATP (Fig. III-
10B).  The rate of the change in the light scattering of acto-M10IQ1 increased with ATP, 
but unlike the result shown in Fig. III-4, the rate was saturated at lower ATP 
concentration to yield the maximum rate of 23 ± 2.0 s-1.  This is explained by the ADP 
dissociation step (k’+5) from acto-M10IQ1.  Fig. III-10C shows the change in pyrene-
actin fluorescence intensity upon mixing pyrene-actin/M10IQ1/ADP with ATP.  The 
time course of the fluorescence change was fitted by two exponential kinetics yielding 
the fast and slow rate constants of ~500 s-1 and 23 ± 1.5 s-1, respectively. The ADP 
dissociation rate constants obtained from the two different experiments were in good 
agreement, hence assigning 23 s-1 for k’+5. The affinity of acto-M10IQ1 for ADP as 
calculated from these results (K’5K’6) was 8.8 ± 4.4 µM, a value consistent with the KADP 
value of 6.4 µM obtained in the steady-state actin-activated ATPase measurement 
(Homma et al., 2001).  The ADP dissociation rate was two times larger than the Vmax of 
the steady state ATP hydrolysis cycle rate, indicating that this step is not the sole 
determinant of the ATPase cycle rate, although it contributes to the rate limitation of the 
ATP hydrolysis cycle to a certain extent.  The rate of ADP dissociation was significantly 
increased by actin by approximately 100-fold. 
 
Kinetics of actin binding and dissociation 
The rate of actin binding to M10IQ1 was measured using pyrene-actin.  The 
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fluorescence intensity of pyrene actin rapidly decreased upon the addition of M10IQ1 as 
a result of the binding of M10IQ1 to pyrene-actin (Fig. III-11A, inset).  The binding rate 
constant increased linearly with actin concentration to yield a second order rate constant 
of 4.1 ± 0.2 µM-1s-1.  The dissociaton rate constant of 1.4 ± 0.2 s-1 was obtained from the 
y-intercept (Fig. III-11A). 
The dissociation rate constant of actin from acto-M10IQ1 was also measured by 
mixing an excess amount of non-labeled actin with the pyrene-acto-M10IQ1 complex.  
The fluorescence intensity of pyrene-actin increased upon mixing, reflecting the 
dissociation of pyrene-actin from acto-M10IQ1 complex (Fig. III-11B).  The observed 
rate constant of 1.3 ± 0.1 s-1 agrees well with the y-intercept of Figure III-11A.  Based on 
these results, Kd (K12) of acto-M10IQ1 in the absence of nucleotides is estimated to be 
0.3 µM.  This value is much higher than those of other known myosins, indicating that 
the rigor binding of acto-myosin 10 is much weaker than those of other myosins. 
The rate of actin binding to M10IQ1 was also measured in the presence of ADP 
using the same procedure.  The time course of the change in pyrene fluorescence 
intensity was best fitted with double exponential kinetics (Fig. III-12A, inset).  Both the 
fast and the slow phases showed linear actin concentration dependence.  The second 
order rate constants of the fast and slow phases were 1.3 ± 0.1 µM-1s-1 and 0.13 ± 0.02 
µM-1s-1, respectively (Fig. III-12A).  From the y-intercepts of the two phases, the rate 
constants for actin dissociation were estimated to be 1.7 ± 0.1 s-1 and 0.12 ± 0.02 s-1 for 
the fast and the slow phases, respectively.  The dissociation of actin from acto-
M10IQ1/ADP was measured by monitoring the fluorescence change of pyrene-actin upon 
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mixing pyrene-acto-M10IQ1/ADP with excess non-labeled actin (Fig. III-12B).  The 
increase in the pyrene fluorescence intensity followed single exponential kinetics and 
yielded the rate constant for actin dissociation of 2.1 s-1.  This value is consistent with the 
value obtained from the fast phase in Figure III-12A.  The identity of the slow phase 
observed in Figure III-12A is unclear.  Based upon these rate constants, the affinity of 
actin to M10IQ1/ADP was calculated to be 1.6 µM that is significantly weaker than those 
of other unconventional myosins such as myosin 1C (55 nM) (El Mezgueldi et al., 2002), 
myosin 5a (7.6 nM) (De La Cruz et al., 1999) and myosin 6 (47 nM) (De La Cruz et al., 
2001).  Consistently, a significant amount of M10IQ1 was recovered in the supernatant 
when M10IQ1(1µM) was co-precipitated with actin (5 µM) in the presence of ADP (Fig. 
III-12B, inset).  The fraction of M10IQ1 in the supernatant and pellet was determined by 
densitometry to be 22 % and 78 %, respectively.   These values agree well with the 
calculated values, i.e., 27% and 73% in the supernatant and pellets, respectively, based 
upon the Kd=1.6 µM estimated from the dissociation and binding rate constants. 
 
Duty ratio of myosin 10 
All rate constants and equilibrium constants obtained in the present study are 
summarized in Table III-1.  The overall ATPase rate of myosin 10 in the absence of actin 
is explained by the fast equilibrium of K3 (0.85), k+4 (0.13 s-1) and k+5 (0.28 s-1).  The 
ATPase rate can be estimated to be ~0.04 s-1, which agrees with the experimentally 
determined basal ATPase rate of 0.065 ± 0.035 s-1.  Likewise, in the presence of actin, the 
overall ATPase rate and the KATPase of acto-M10IQ1 (13.5 s-1 and 17.4 µM, respectively) 
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can be explained by the ATP hydrolysis rate (k+3 + k-3 = ~400 s-1 ,K3 = 0.85),  the actin 
reassociation rate (k’+4/K9 = 1.54 µM-1s-1), the phosphate release rate (k’+4 > 100 s-1) and 
the ADP release rate (k’+5 = 23 s-1).  The major kinetic pathway of myosin 10 is shown in 
bold in scheme III-1. The broken line in Figure III-1B shows computer simulation of the 
steady-state ATPase of M10IQ1 under saturating ATP with ATP regeneration system 
using the rate constants and the equilibrium constants obtained in the present study 
(Appendix D).  Contribution of k+4, [M] and [MD] to the overall ATPase rate was 
ignored for simplicity of the simulation.  The initial values, rates and equilibrium 
constants employed in the simulation were as follow.  [AM]0 = 1 µM, [AMT]0 = [MT]0 = 
[MDP]0 = [AMDP]0 = [AMD]0 = 0 µM, K’1k’+2[ATP]= 800 s-1, K8 = 100 µM (rapid 
equilibrium), k+3 = 184 s-1, k-3 = 216 s-1 (K3 = 0.85), K9 = 65 µM (rapid equilibrium), 
k’+4/K9 = 1.54 µM-1s-1, k’+4 = 100 s-1, k’+5 = 23 s-1. The simultaneous differential equation 
was solved by Runge-Kutta 4th approximation with calculation time interval of 50 µsec.  
A typical example of the simulation at 10 µM actin is shown in Figure III-13.  Halving 
and doubling the time interval did not affect the result (data not shown).  Vmax and KATPase 
calculated by this simulation were 13.3 s-1 and 17.7 µM, respectively, and these values 
were in good agreement with the experimentally obtained values. It should be noted that 
K8 value in the range of 50 µM ~ 200 µM can explain the steady-state ATPase rate (13.5 
± 1.6 s-1). The duty ratio of myosin 10 at maximal actin condition was estimated to be 
~0.6. 
 
Duty ratio of myosin 10 indirectly estimated from steady-state assays 
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The duty ratio can be indirectly estimated by comparing a KATP value obtained 
from an ATPase assay at saturating actin (Km ATPase) with a KATP value obtained from an 
ATP-dependent in vitro actin gliding assay (Km motility).  This criterion has been employed 
to evaluate duty ratio of other motor proteins (deCastro et al., 1999; Tominaga et al., 
2003).   If we define the total time taken for completion of a single ATPase cycle at 
saturating ATP as Ttotal, myosin spends Ttotal waiting for next ATP binding at Km ATPase 
where myosin takes 2 x Ttotal for each cycle (thus K’1k’+2 x Km ATPase = 1/Ttotal).  Likewise, 
when we define attachment time of myosin to actin during ATPase cycle at saturating 
ATP as Ton, Km motility is the ATP concentration at which a myosin spends Ton waiting for 
next ATP binding (thus K’1k’+2 x Km motility = 1/Ton).  Since the duty ratio is defined as 
Ton/Ttotal, the duty ratio can also be defined as Km ATPase/Km motility.  We performed an ATP 
dependent in vitro motility assay (Fig. III-14A) and steady-state ATPase assay at various 
actin concentrations on M10IQ1 (Fig. III-14B). The Km motility value obtained from this 
experiment was 6.1 ± 0.7 µM, which is consistent with the value previously obtained for 
the HMM-like myosin 10 construct (5.6 µM) (Homma et al., 2001).  The Km ATPase is 
actin dependent, and the maximal Km ATPase value was estimated to be 4.3 ± 0.5 µM.  
Thus the duty ratio of M10IQ1 is calculated to be 0.70 ± 0.11, which is in good 
agreement with the duty ratio estimated from the computer simulation using rate 
constants obtained in the kinetics experiment (~0.6).   
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Discussion 
 
Overview 
In this chapter, we analyzed the enzyme kinetic mechanism of the acto-myosin 10 
ATP hydrolysis cycle.  Based on the obtained results, we concluded that myosin 10 is a 
high duty ratio motor (the duty ratio > 0.5).  We found several unique features for the 
acto-myosin 10 ATPase reaction.  First, the strong actin binding state (AMD) of myosin 
10 is much weaker than other known myosins. The dissociation constant for the binding 
of myosin 10/ADP (AMD) to actin is 1.6 µM, which is significantly larger than those for 
myosin 1C (55 nM), myosin 5a (7.6 nM) and myosin 6 (47 nM) (De La Cruz et al., 2001; 
De La Cruz et al., 1999; El Mezgueldi et al., 2002).  The result was also confirmed by 
actin cosedimentation in the presence of ADP, in which a significant fraction of myosin 
10 was recovered in the supernatant (Fig. III-12B, inset).  Second, phosphate release step 
is not the rate-limiting step of acto-myosin 10 ATPase cycle despite its fast ADP release 
rate (2-fold larger than the Vmax). Third, the equilibrium of ATP hydrolysis step is 
significantly shifted to MT and approximately equal fractions of MT and MDP are 
present in the ATPase cycle.  This small burst size contributes to the overall ATPase rate 
of myosin 10 by reducing the fraction of AMDP. 
Kovacs et al. (Kovacs et al., 2005) also reported kinetic mechanism of 
subfragment-1 like myosin 10 ATPase (Their construct is also single-headed, but it 
contains the whole three IQ motifs).  There are several major differences between our 
conclusions and theirs.  First, the rate of the entire ATPase cycle obtained in this study is 
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nearly three times larger than that reported by Kovacs et al. (2005).  The Vmax of HMM-
like myosin 10 reported in our previous study was also smaller than the Vmax obtained in 
the present study.  The difference can be explained by the accuracy of the determination 
of protein (or active site) concentration. In the present study, we directly determined the 
active site concentration by measuring the radioactive ADP incorporated into M10IQ1 in 
the presence of vanadate (Fig. III-15).  This enabled us to determine the effective protein 
concentration much more accurately than the routine methods such as dye binding 
methods or the biuret method.  It should be noted that in the case of myosin 10 the 
conventional active site titration method using ATP or mant-ATP would not provide 
accurate estimation due to the presence of significant reverse reaction of the ATP binding 
step (k-2).  Second, they found a slow Pi off phase from myosin 10 in the presence of 
actin and argued that this was due to the attached hydrolysis.  Based on our results, we 
think that the slow Pi off phase is not derived from the “attached hydrolysis”, but due to 
the slow rebinding of ATP.    
 
Attached hydrolysis pathway (AMT–AMDP) 
Kovacs et al. (Kovacs et al., 2005) suggested that the slow “attached hydrolysis” 
plays a significant role in the acto-myosin 10 ATPase cycle.  This conclusion was due to 
the finding of a slow Pi off phase in the Pi release kinetics of acto-myosin 10. We also 
measured the dual phase kinetics for phosphate release in the presence of actin, and the 
result was very similar (Fig. III-7).   However, since the slow rate was M10IQ1 
concentration dependent, we concluded that the slow phase is derived from ATP 
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rebinding due to the reverse reaction (k-2 = ~1 s-1).  Actually, our model explained the 
overall ATPase cycle very well without the slow attached hydrolysis (Fig. III-1B, broken 
line).  Furthermore, the presence of the slow attached hydrolysis pathway in the ATPase 
cycle of myosin 10 is inconsistent with the results of actin gliding assay. We obtained a 
Km motility value of 6.1 µM for M10IQ1 (Fig. III-14A).  If Ton is defined as the actin 
attached time of M10IQ1 during the ATPase cycle at a saturating ATP condition, the half 
velocity of M10IQ1 can be explained by adding an additional Ton time for ATP binding 
at the ATP concentration of Km motility.   The ATP binding rate at 6.1 µM ATP is 21 s-1 
(3.4 µM-1s-1 x 6.1 µM), which is close to k’+5 (23 s-1) for acto-M10IQ1. Since all myosins 
involved in the translocation of actin filaments are under a saturating actin condition in an 
in vitro motility assay, if there is a slow ~1 s-1 weakly actin bound ATP hydrolysis step, 
the Ton will be predominantly determined by the slow step (~1 s-1).  In this case, the Km 
motility value has to be ~0.3 µM, which is inconsistent with the experimentally determined 
value of 6.1 µM. Therefore, we propose that attached hydrolysis pathway (AMT–AMDP) 
is negligible, if any, under the condition we employed in the present study. The k-2 of ~1 
s-1 would also affect the estimation of K3 determined by the single turnover quenched-
flow experiment, since the experiment also employed very low concentration of ATP.  
The K3 value of 0.85 was determined by assuming k-2 = ~0 s-1.  If we assume k’-2 = 1 s-1 
under the condition we measured the burst size (1µM M10IQ1 and 0.5 µM ATP, Fig. III-
6A), approximately 15% of ATP remains unbound to M10IQ1.  Thus, the actual K3 
value, which should be estimated from the apparent burst size of 0.46 (Fig. III-6A), will 
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be 1.18 instead of 0.85.  However, this change does not influence our overall kinetic 
model. 
  
So, is myosin 10 processive? 
It has been thought that the processive movement of a two-headed myosin 
requires a duty ratio of greater than 0.5.  For example, myosin 5a, a well-known 
processive myosin, has a duty ratio of >0.7.  The duty ratio of myosin 10 obtained from 
the present study was 0.6 ~ 0.7, and it could be even higher at physiological temperature 
(~37oC).  The fraction of AMD intermediate is significantly reduced due to the 
unfavorable equilibrium of the hydrolysis step (K3 = 0.85) under the experimental 
condition in the present study (25oC).  However, as pointed out previously on myosin 5a 
(De La Cruz et al., 2000), the hydrolysis equilibrium (K3) may greatly increase at 
physiologic temperature (~37oC), which increases the fraction of AMD, thus the duty 
ratio.  Therefore, it is very likely that myosin 10 is a processive motor when it is 
dimerized. 
All two-headed processive myosins characterized so far have high duty ratios 
(>0.5), however, having a high duty ratio itself does not guarantee a processive 
movement.  In Chapter IV, we directly tested the processivity of myosin 10 with a single 
molecule observation assay system. 
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Figure III-1.  Recombinant myosin 10 construct (M10IQ1).  A. Purification of M10IQ1. The 
M10IQ1 expressed in Sf9 cells were extracted and purified as described in the text, and the 
purified protein was analyzed by SDS-PAGE.  HC and CaM represent the heavy chain of myosin 
10 construct and calmodulin, respectively. B. Actin dependence of the Mg2+ATPase activity of 
M10IQ1. ATPase activity was measured as described in the text. The solid curve is the best fit to 
Michaelis-Menten kinetics with Vmax and KATPase of 13.5 head-1s-1 and 17.4 µM, respectively.  The 
broken line is simulated based on rate constants obtained in the present study (see Discussion), 
which gave Vmax and KATPase of 13.3 s-1 and 17.7 µM, respectively. The error bars represent 
standard error from three independent experiments.  C. in vitro motility activity of M10IQ1.  in 
vitro motility assay was performed as described in the text with 0.1mM ATP.  The velocity was 
0.17 ± 0.03 µm s-1. 
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Figure III-2.  Calmodulin-dependent ATPase activity of M10IQ1.  The ATPase activity of 
M10IQ1 was measured using 50 nM M10IQ1, 50 units/ml pyruvate kinase, 1 mM 
phosphoenolpyruvate, 1 mM ATP, 5 µM actin, and various concentrations of calmodulin (CaM) 
in buffer B at 25oC.  The apparent dissociation constants of calmodulin were 2.7 ± 1.2 µg/ml and 
1.4 ± 0.2 µg/ml, in the presence (0.1 mM) and the absence of Ca2+, respectively. 
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Figure III-3.  Mant-ATP binding to M10IQ1 and acto-M10IQ1.  The rate constants of Mant-
ATP binding to M10IQ1 (square) and acto-M10IQ1 (triangle) as a function of Mant-ATP 
concentration are shown.  The observed rate constants (kobs) were obtained by fitting the time 
course of the change in fluorescence of Mant-ATP upon the binding to M10IQ1 at each 
concentration to a single exponential.  The insets show typical recordings of Mant-ATP (1 µM) 
binding to M10IQ1 (0.25 µM) in the absence (A) and the presence of 1 µM actin (B). The 
concentrations indicate the final concentrations after mixing.  Apparent second order binding rate 
constants of 4.7 µM-1s-1 and 3.4 µM-1s-1 were obtained for Mant-ATP binding to M10IQ1 and 
acto-M10IQ1, respectively. The solution condition was 25 mM KCl, 25mM Hepes-KOH (pH 
7.5), 5mM MgCl2, 1 mM EGTA and 0.2 mg/ml calmodulin at 25oC.  The error bars represent the 
standard error from 3-6 independent experiments.   
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Figure III-4.  ATP-induced dissociation of acto-M10IQ1 and the formation of weak actin 
binding form of M10IQ1.  ATP-induced acto-M10IQ1 dissociation and weak actin binding 
formation were monitored by light scattering (square) and pyrene-actin fluorescence (circle).   
Inset shows the typical recordings of the time course of light scattering change (lower trace) and 
pyrene fluorescence change at 25 µM ATP (final).  Apparent rates were obtained by single 
exponential fitting. At high ATP conditions, the initial signal changes were missed due to the 
dead time of the instrument.  However, approximately 30-40% of the total signal could be 
monitored after the dead time even at the rate constant of 700s-1, and this was sufficient to 
determine the rate constant.  Concentrations of M10IQ1 and actin (or pyrene-actin) after mixing 
were both 0.25 µM.  Other conditions were the same as in Fig. III-3.  The error bars represent the 
standard error from 3-6 independent experiments.  
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Figure III-5.  ATP-induced enhancement of intrinsic tryptophan fluorescence intensity of 
M10IQ1.  0.5 µM (in final) M10IQ1 was mixed with various concentrations of ATP and the 
change in tryptophan fluorescence was monitored.  Apparent rates were obtained by single 
exponential fitting and plotted against ATP concentration.  The inset shows a typical recording of 
the experiment at 2.5 µM (final) ATP.  The maximal rate of 395 ± 26 s-1 was obtained. Reaction 
conditions were the same as in Fig. III-3.  The error bars represent the standard error from 3-5 
independent experiments. 
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Figure III-6.  ATP hydrolysis by M10IQ1.  A. Single turnover experiment. 1 µM (after 
mixing) M10IQ1 was mixed with 0.5 µM (after mixing) [γ-32P]ATP and the fraction of 
hydrolyzed ATP was plotted against time.  The result was best fitted by double exponential 
kinetics.  The apparent rates of the fast and slow phases were 2.7 s-1 and 0.06 s-1, respectively. 
The fractional amplitude of 0.46 was obtained from the fitting.   B.  Multi turn-over 
experiment. 1 µM (after mixing) M10IQ1 was mixed with 10.7 µM (square) or 20.9 µM 
(triangle) (after mixing) [γ-32P]ATP and the rate of ATP hydrolysis was measured by single 
exponential fitting.  The apparent rate constants were 65 ± 10 s-1 and 124 ± 57 s-1, respectively.  
The Pi-burst sizes estimated from the fitting were 0.40 ± 0.02 and 0.44 ± 0.07, respectively. 
Conditions in A and B were the same as in Fig. III-3.  The error bars represent standard error 
from three independent experiments. 
60
  
 
Figure III-7.  Phosphate release from M10IQ1.  Phosphate release from M10IQ1 was 
monitored through MDCC-PBP fluorescence enhancement upon binding to phosphate released 
from M10IQ1 by double mixing experiment.  1 µM M10IQ1 was first mixed with 0.7 µM ATP, 
and aged for 5 s. Then the solution was mixed with various concentration of actin (0 – 150 µM).  
Since the volume ratio of the syringes was 1:1:1, the final concentrations were 1/3 of the 
originals.  A. Typical recording of the MDCC-PBP fluorescence enhancement at 0 µM actin.  
The change in fluorescence was best fitted by single exponential and the apparent rate was 0.06 s-
1.  The inset shows MDCC-PBP fluorescence enhancement at 5 µM (in final) actin.  The transient 
was best fitted by double exponential and the apparent rates were 5.6 s-1 and 0.4 s-1. B. Actin-
dependence of the apparent rate constants of the fast and slow phases.  The actin 
concentrations indicated are the final concentration.  The fast phase was actin-dependent with the 
apparent second order rate constant of 0.71 µM-1s-1, while the slow phase was actin-independent. 
The inset shows the apparent rate constants of the slow phase as a function of M10IQ1.  The 
reaction condition was the same as in A except 5 µM actin (in final) and various concentrations of 
M10IQ1 were employed.  The x-axis indicates the final concentration (after mix) of M10IQ1. 
All solutions contained buffer B with 0.2 mg/ml calmodulin, 0.01 units/ml PNPase, 0.3 mM 
MEG and 3 µM MDCC-PBP.   The error bars represent the standard error of the 3-5 independent 
experiments. 
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Figure III-8.  Effect of phosphate on the ATPase activity of M10IQ1. The ATPase activity of 
M10IQ1 was measured under the condition of 0.75 µM M10IQ1, 50 units/ml pyruvate kinase, 2 
mM phosphoenolpyruvate, 2 mM ATP, 5 µM actin, 0.2 mg/ml calmodulin in buffer B, and 
various concentrations of phosphate at 25oC.  Note that the actual concentration of phosphate 
increases as the reaction proceeds. 
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Figure III-9.  The interaction of mant-ADP with M10IQ1.  A.  Binding of mant-ADP to 
M10IQ1.  The rate constants of mant-ADP binding to M10IQ1 as a function of mant-ADP 
concentration are shown.  The apparent rate constants (kobs) were obtained by fitting the time 
course of the change in fluorescence of mant-ADP upon binding to M10IQ1 at each concentration 
to a single exponential. The inset shows a typical recording of the mant-ADP fluorescence change 
at 0.25 µM M10IQ1 and 5 µM mant-ADP (in final).  The observed rate constant showed 
hyperbolic dependence on mant-ADP concentration to yield kmax of 1.11 ± 0.07 s-1 and Km of 3.6 
± 1.1 µM.  B.  Dissociation of mant-ADP from M10IQ1.  3 mM ATP was added to the mixture 
of 1 µM M10IQ1 and 5 µM mant-ADP, and the time course of the decease in the fluorescence 
intensity due to mant-ADP dissociation was monitored.  The time course showed a single 
exponential kinetics to yield a kobs of 0.27 s-1.  Conditions were the same as in Fig. III-3. The error 
bars represent standard error from three independent experiments.  
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Figure III-10.  The interaction of mant-ADP with acto-M10IQ1.  A. Binding of mant-ADP 
to acto-M10IQ1.  The mixture of 1 µM M10IQ1 and 2 µM actin was mixed with various 
concentrations of mant-ADP.  The final concentrations are half of the originals. The change in the 
fluorescence intensity showed single exponential increase, and the apparent rates (kobs) were 
plotted against mant-ADP concentration. The indicated mant-ADP concentrations are the final 
concentrations.  The inset shows a typical recording of mant-ADP fluorescence change at 2µM 
mant-ADP (in final).  B.  Dissociation of ADP from acto-M10IQ1/ADP complex.  The mixture 
of 0.5 µM M10IQ1, 1 µM actin and 0.1 mM ADP was mixed with various concentrations of 
ATP, and the dissociation rate of acto-M10IQ1 was monitored by measuring the light scattering 
intensity.  The time course of light scattering intensity was analyzed by single exponential fitting 
as in Fig. III-4, and the apparent rates were plotted against ATP concentration. C. ADP release 
from pyrene-acto-M10IQ1.  The mixture of 1 µM M10IQ1, 1 µM pyrene-actin and 0.2 mM 
ADP was mixed with 1 mM ATP (before mix), and the change in pyrene-actin fluorescence 
intensity was monitored.  The transient showed a double exponential kinetics to yield 503 s-1 and 
23.5 s-1 with approximately 1:1 amplitude ratio. Conditions were the same as in Fig. III-3. The 
error bars represent standard error from 3-4 independent experiments. 
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Figure III-11.  Actin binding to M10IQ1 in the absence of ADP.  A.  Actin binding to 
M10IQ1. 0.25 µM M10IQ1 and various concentrations of pyrene-actin were mixed and the 
decrease in the fluorescence signal due to the binding of the two proteins was monitored.  The 
inset shows a typical recording of the experiment performed at 0.5 µM actin.  The transients 
followed single exponential kinetics and the apparent rate were plotted against pyrene-actin 
concentration.  B.  Dissociation of actin from M10IQ1.   The mixture of 1 µM M10IQ1 and 1 
µM pyrene-actin was mixed with an excess amount of non-labeled actin (40 µM before mix), and 
the increase in the fluorescence signal of pyrene-actin was monitored.  The apparent rate of 1.3 s-1 
was obtained from single exponential analysis. Conditions were the same as in Fig. III-3. The 
error bars represent standard error from three independent experiments. 
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Figure III-12.  Actin binding to M10IQ1 in the presence of ADP.  A.  Actin binding to 
M10IQ1.  The mixture of 0.5 µM M10IQ1 and 0.2 mM ADP was mixed with various 
concentrations of pyrene-actin premixed with  0.2 mM ADP, and the change in pyrene-actin 
fluorescence intensity was monitored. The inset shows a typical example of the experiment done 
at 1 µM (after mix) pyrene-actin.  The fluorescence transients followed double exponential 
kinetics and both the fast (circle) and the slow (square) apparent rates were plotted against 
pyrene-actin concentration. The error bars represent standard error from three independent 
experiments.  B.  Dissociation of actin from M10IQ1.   The mixture of 1 µM M10IQ1, 1 µM 
pyrene-actin and 0.2 mM ADP (before mix) was mixed with excess amount of non-labeled actin 
(40 µM before mix) with 0.2 mM ADP, and the increase in the fluorescence signal of pyrene-
actin was monitored. The apparent rate of 2.1 s-1 was obtained from single exponential fitting.  
Inset.  Co-precipitation of M10IQ1 with actin in the presence of ADP.  Mixture of 1 µM 
M10IQ1, 5 µM actin and 0.1 mM ADP was subjected to ultracentrifugation.  The supernatant and 
pellets were subjected to SDS-PAGE followed by densitometry to quantitate the amount of 
proteins.  22% of M10IQ1 was found in the supernatant.  
Experimental conditions were the same as in Fig. III-3.  
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Figure III-13.  Computer simulation of the ATPase reaction of M10IQ1 at 10 µM actin. The 
initial values, rates and equilibrium constants employed in the simulation were as follow.  [AM]0 
= 1µM, [AMT]0 = [MT]0 = [MDP]0 = [AMDP]0 = [AMD]0 = 0µM, K’1k’+2[ATP]= 800 s-1, K8 = 
100 µM (rapid equilibrium), k+3 = 184 s-1, k-3 = 216 s-1 (K3 = 0.85), K9 = 65 µM (rapid 
equilibrium), k’+4/K9 = 1.54 µM-1s-1, k’+4 = 100 s-1, k’+5 = 23 s-1. The simultaneous differential 
equation was solved by Runge-Kutta 4th approximation with calculation time interval of 50 µsec. 
Contribution of k+4, [M] and [MD] to the overall ATPase rate was ignored for simplicity of the 
simulation. See also Appendix D. 
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Figure III-14.  Km motility and Km ATPase of M10IQ1. A. ATP-dependence of the actin gliding 
activity of M10IQ1.  Actin translocating velocity of M10IQ1 under various concentrations of 
ATP was measured and the velocities were plotted against ATP concentrations.  Km motility value of 
6.1 ± 0.7 µM was obtained from hyperbolic analysis.  The error bars represent SD (n = 90~150). 
B. actin-dependence of Km ATPase of M10IQ1. ATP-dependence of the actin-activated ATPase 
activity was measured at various actin concentrations and the Km ATPase were plotted against actin 
concentration. The error bars represent standard error from three independent experiments. 
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Figure III-15.  Active site titration by ADP-Vi. 0.5µM M10IQ1 (determined by Bradford 
method by taking BSA as a control) was mixed with 1 mM VO4 and various concentrations of 
[2,8-3H]ADP (indicated in the x-axis) in buffer B. After 3 hr of incubation at 4oC, the mixture was 
subjected to G-50 spin-column equilibrated with buffer B.  The radioactivity of the elution was 
determined and normalized by dividing by the apparent protein concentration determined by 
Bradford method.  The normalized value saturated at 0.3µM [2,8-3H]ADP, indicating that the 
actual concentration of active M10IQ1 was 0.3µM instead of 0.5µM. 
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 CHAPTER IV 
PROCESSIVITY OF MYOSIN 10 
 
Introduction 
 
It has been thought that a processive motor, having a high duty ratio, is suitable 
for cargo transport.  In the myosin superfamily, myosin 5a has a high duty ratio (De La 
Cruz et al., 1999), and it has been shown to be a cargo transporting motor, which moves 
melanosomes in melanocyte, endoplasmic reticulum in the giant axons of the squid 
nervous system (Tabb et al., 1998), and synaptic vesicles in brain (Brown et al., 2004; 
Evans et al., 1998; Prekeris and Terrian, 1997).  Biochemical and biophysical studies 
demonstrated that myosin 5a is a processive motor that travels on an actin filament for a 
long distance without dissociating from the actin track (Mehta et al., 1999; Sakamoto et 
al., 2000; Tanaka et al., 2002; Veigel et al., 2002).  Myosin 5a exists as a stable 
homodimer, and its processive movement has been explained by hand-over-hand 
mechanism using the two heads at a high duty ratio (Warshaw et al., 2005; Yildiz et al., 
2003). 
Similarly to myosin 5a, recent cell biological studies suggest that myosin 10 
transport cargos such as VASP (Tokuo and Ikebe, 2004) and β-integrin (Zhang et al., 
2004) inside filopodia.  In Chapter III, we found that the duty ratio of myosin 10 is higher 
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than 50%, suggesting that myosin 10 is a processive motor.  These findings strongly 
suggest that myosin 10 functions as a cargo transporter in a cell. 
Unlike myosin 5a, however, the predicted coiled-coil region of myosin 10 does 
not form a stable coiled-coil, and a recombinant HMM-like myosin 10 (truncated after 
the predicted coiled-coil region) has been reported to be predominantly monomeric by 
itself (Knight et al., 2005).  Interestingly, the first one-third of the predicted coiled-coil 
region of myosin 10 is very similar to a part of the predicted coiled-coil region of myosin 
6 in terms of the poor hydrophobic seam and high proportion of the charged residues, 
which prevents the region from forming stable coiled-coil.  This highly charged region 
forms a stable α helix (SAH) instead of coiled-coil (Knight et al., 2005).  Myosin 6 has 
been reported to be a high duty ratio motor with ADP off as the predominant rate-limiting 
step.  Like myosin 10, it is predominantly monomeric by itself (Lister et al., 2004).  The 
monomeric form of myosin 6 is nonprocessive (Lister et al., 2004), however, it becomes 
processive when dimerized (Nishikawa et al., 2002; Rock et al., 2001). Most of the 
predicted coiled-coil region of Myosin 7, another high duty ratio motor, is also very 
similar to the SAH regions of myosin 6 and myosin 10.  Like myosin 6, myosin 7 
becomes processive when it is dimerized (Yang et al., 2006).  Thus, it is very likely that 
myosin 10 becomes processive when dimerized, thus functions as a transporter.  Myosin 
10 constructs lacking the coiled-coil region did not localize at the tips of filopodia, and 
overexpression of the coiled-coil region alone has a dominant negative effect on the 
intrafilopodial motility of endogenous myosin 10 (Bohil et al., 2006), suggesting that the 
dimerization of myosin 10 is essential for the function. 
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To directly test the processivity of myosin 10, we observed single molecule 
movements of force-dimerized myosin 10 constructs along actin filaments by a total 
internal reflection microscope (TIRFM). 
 
Materials and methods 
 
Materials - Bovine serum albumin (BSA) was purchased from Sigma (St. Louis, Mo).  
Alexa Fluor 647 phalloidin and streptavidin were purchased from Invitrogen 
(Carlsbad,CA). Biotin-maleimide (EZ-link PEO-Maleimide Activated Biotin) was 
purchased from Pierce (Rockford, IL).  For other materials, see “Materials and methods” 
in Chapter II. 
 
Force-dimerized myosin 10 constructs - An N-terminal tagging vector that introduces a 
FLAG epitope tag and an eGFP was prepared by modifying the pFastBac vestor.  Partial 
ORFs of bovine myosin 10 (Met1–Ser916, Met1-Lys883, and Met1–Ala939) with 5’-SalI 
site and 3’-HindIII site were ligated into the modified pFastBac vector treated with SalI 
and XbaI together with a partial ORF of mouse myosin 5a (the stable coiled-coil helix 
region: Leu908 – Glu1090 plus stop codon) with 5’-HindIII site and 3’-XbaI site.  The 
HindIII site inserts two additional amino acids (lysine and leucine) at the junctions of 
myosin 10 and myosin 5a of these constructs (GFPM10M5cc1, GFPM10M5cc2, and 
GFPM10M5cc3).  Three additional chimeric constructs (GFPM10M5IQcc1, 
GFPM10M5IQcc2, and GFPM10M5IQcc3) were also produced by the two-step PCR 
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method (Zarrinpar et al., 2003), and ligated into the modified pFast vector with SalI site 
and XbaI site at 5’-side and 3’-side, respectively. 
 
Baculovirus preparation - See “Materials and methods” in Chapter II. 
 
Protein expression and purification - See “Materials and methods” in Chapter II. 
 
Preparation of biotin-labeled BSA - BSA was dissolved in a buffer containing 100 mM 
NaCl, and 50 mM Tris-HCl, pH 8.3, and mixed with 10 molar excess of biotin-maleimide 
for an hour at 23oC.  The reaction was terminated by 25 mM DTT, and dialyzed 
extensively against a dialysis buffer containing 50 mM NaCl, 10 mM Tris-HCl, pH 7.5, 
and 1 mM DTT at 4oC to eliminate free biotin. 
 
Preparation of biotin-labeled G-actin - G-actin was freshly prepared according to the 
method by Spudich and Watt (Spudich and Watt, 1971), and the extracted G-actin (180 
µM) was mixed with 1.5 molar excess (270 µM) of biotin-maleimide for overnight at 4oC 
in a buffer containing 2 mM HEPES-KOH, pH 7.8, 0.2 mM ATP, 0.1 mM CaCl2.  The 
reaction was terminated by adding 3 mM DTT.  The biotin-G-actin was diluted to 5 µM, 
and flash-frozen to store at -80 oC. 
 
Alexa 647 phallodin-labeled F-actin - The biotin-G-actin was premixed with unlabeled-
G-actin at various ratios while maintaining the total actin concentration at ~ 1 µM, and 
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then put into a buffer containing 25 mM KCl, 25 mM HEPES-KOH, pH 7.5, 5 mM 
MgCl2, 1 mM EGTA, 1 mM DTT, and 40 units/ml Alexa Fluor 647 phalloidin.  The 
solution was kept in the dark for overnight at 4oC. 
 
In vitro motility assay - See “Materials and methods” in Chapter II. 
 
Total internal reflection microscope (TIRFM) - A prism type total internal reflection 
microscope was built on an inverted microscope platform (IX71, Olympus).  A 473 nm 
diode laser (DPBL-9040, Photop) and a 635 nm diode laser (Radius 635-25, Coherent) 
were used to excite GFP and Alexa Fluor 647, respectively.  The fluorescence signals 
from GFP and Alexa Fluo 647 were collected by a high NA objective lens (PlanApo 60X 
OIL; NA = 1.45, Olympus), and were passed through the W-VIEW apparatus (A-8509, 
Hamamatsu Photonics) that contained two dichroic mirrors (560DCLP and 600DCSP, 
Chroma) and two band pass filters (HQ520/40m for GFP and HQ700/75m for Alexa 647 
Fluor, Chroma).  The fluorescence signals were imaged by a CCD video camera 
(MC681SPD, Texas Instruments) with an image intensifier (C8600, Hamamatsu 
Photonics) (Appendix E). 
 
Single molecule experiment - 1 mg/ml biotinylated BSA was applied to a ~20 µl flow 
chamber made of two coverslips coated with nitrocellulose.  After 2 min of incubation at 
room temperature, unbound biotin-BSA was washed away with buffer M (25 mM KCl, 
25 mM HEPES-KOH, pH7.5, 5 mM MgCl2, and 1 mM EGTA).  Streptavidin (0.1 
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mg/ml) was applied to the flow chamber and incubated for 3 min at room temperature.  
Unbound streptavidin was washed out with buffer M.  Biotinylated F-actin labeled with 
Alexa Fluor 647 phalloidin was applied to the chamber, and incubated for 2 min at room 
temperature.  Finally, a GFP-labeled myosin construct in buffer M containing 0.2 mg/ml 
calmodulin, 2 mM ATP, 4.5 mg/ml glucose, 36 µg/ml catalase, 216 µg/ml glucose 
oxidase, 143 mM 2-mercaptoethanol was applied to the flow chamber. GFP and Alexa 
647 Fluor fluorescence signals were simultaneously visualized by the TIRF microscope 
setting described above, and the movement of the GFP signal was monitored at 30 frames 
/ sec. 
 
Results 
 
Generation of force-dimerized myosin 10 constructs using the stable coiled-coil of 
myosin 5a 
The predicted coiled-coil region of myosin 10 consists of ~140 amino acids (Fig. 
IV-1).   The first one-third of the region contains a large number of charged amino acids, 
and recently this highly charged region has been reported to form a stable alpha helix 
(SAH), rather than a coiled-coil (Knight et al., 2005).  As a result of the SAH formation, 
the actual length of the neck region of myosin 10 becomes longer than initially predicted 
(equivalent to 5~6 IQ motifs).  The coiled-coil registration in the remaining two-thirds of 
the predicted coiled-coil region is not clear, and this may explain why myosin 10 is 
monomeric by itself.  At least three possible coiled-coil registrations were found in the 
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region (Fig. IV-1).  Since it was not clear which registration is the authentic one, we 
generated three different force-dimerized constructs based on these three possible coiled-
coil registrations using the stable coiled-coil region of myosin 5a (Fig. IV-2).  The N-
terminus of each construct was tagged with GFP for single molecule experiments 
described below.  The N-terminal GFP does not interfere with the motor function of 
myosin molecules (Table II-1).  All these constructs were successfully expressed and 
purified (Fig. IV-3). 
We first tested if the force-dimerized GFPM10M5cc constructs retain actin 
translocating activity by the in vitro motility assay (Fig. IV-4).  All chimeric constructs 
showed actin translocating activity, however, the quality and the velocity were different 
from each other.  The actin translocation velocity of GFPM10M5cc1 was ~30% of that of 
the full-length myosin 10 (0.12 ± 0.04 µm/sec).  Many actin filaments dissociated from 
the myosin-coated glass surface and diffused away, suggesting that the construct is not 
processive, because processive myosin 5a under a comparable density on the glass 
surface never shows such actin dissociation.  The actin translocation velocity of 
GFPM10M5cc2 was about two times faster than that of myosin 10 full-length, and the 
movement of actin filaments was relatively smooth compared to the other chimeric 
constructs.  Dissociation of actin filaments from the glass surface was also observed for 
this construct.  The actin translocation velocity of GFPM10M5cc3 was comparable to 
that of myosin 10 full-length, however, the movement of actin filaments was rather 
wiggly as if the construct had problem coordinating the two heads.  Apparently, 
GFPM10M5cc2 seemed to be superior to the other two constructs.  However, since all of 
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the constructs at least retained actin translocating activity and the authenticity of the 
registration of the coiled-coil cannot be determined simply from this observation, we 
tested the processivity of all of these GFPM10M5cc constructs in a single molecule 
experiment. 
 
Single molecule assay 
The best way to determine processivity of myosins is to directly observe the 
successive movement of individual molecules on actin filaments (Sakamoto et al., 
2000)(Fig. IV-5).  The total internal reflection microscope (TIRFM) was employed to 
visualize single GFP fluorescence attached to the myosin constructs (Appendix E).  By 
using TIRFM, less than 200 nm from the glass surface is illuminated by the evanescent 
field, and thus the background noise is highly reduced.  As a positive control, GFP-
labeled myosin 5a was first tested to evaluate the TIRFM system.  As shown in Figure 
IV-5B, successive movements of GFP-labeled myosin 5a molecules on actin filaments 
were observed.  They were indeed single molecules, because the photobleaching events 
were either one- or two-step process as observed in our previous study on GFP-labeled 
dimeric myosin 6 (Nishikawa et al., 2002). 
We performed the single molecule assay on the GFP-myosin 10 full-length 
construct and the GFPM10M5cc constructs under the same condition for GFP-myosin 5a.  
Unlike GFP-myosin 5a, the GFP-myosin 10 full-length construct did not show processive 
movement.  Interestingly, the clustering of the GFP signals, which is usually observed for 
GFP-myosin 10 moving inside filopodia, was not observed.  The result suggests that 
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myosin 10 does not cluster by itself.  Thus, the apparently nonprocessive nature of the 
full-length GFP-myosin 10 can be simply explained by the single-headed structure.  
Contrary to our expectation, none of the GFPM10M5cc constructs showed processive 
movement on actin filaments.  GFP signals frequently appeared on actin filaments, 
however, those signals did not move successively along the actin filaments, suggesting 
that the GFPM10M5cc constructs are not processive.  However, because the lack of 
processive movement might be due to the single-headed structure of the constructs, 
overall structures of the constructs were confirmed by rotary shadowing electron 
microscopy (Fig. IV-6).  As previously reported, the head-neck of myosin 5a is extended, 
and the Y-shape structure can physically allow the myosin 5a molecule to have 36 nm 
step size, which is the half pitch of actin filament (Fig. IV-6). All the GFPM10M5cc 
constructs showed double-headed structure as expected, however, the head-neck region 
of the constructs did not seem to be extended. Rather, it seemed to be bent over the C-
terminal region of the molecules (Fig. IV-6).  This kinked head-neck structure of the 
GFPM10M5cc constructs may explain why they did not show processive movement in 
the single molecule assay.  The result also implies that an additional regulation is 
required to extend the neck region of myosin 10.  In fact, GFP-labeled myosin 10 moves 
back and forth inside filopodia without changing the overall GFP fluorescence intensity 
of the moving spots, suggesting that there is an additional regulatory mechanism other 
than the monomer-dimer transition.  Thus, the kinked structure may represent the inactive 
state of myosin 10 during the retrograde movement of the molecule in the filopodia.  In 
order to bypass this possible regulatory mechanism of myosin 10 to simply evaluate the 
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processivity of dimerized myosin 10 constructs, additional chimeric constructs were 
generated (Fig. IV-7 and Fig. IV-8).  The converter region and the following neck region 
are well conserved among myosin 10 and myosin 5a (Fig. IV-7).  With three different 
joining points, the motor domain of myosin 10 was followed by the neck and the coiled-
coil of myosin 5a (Fig. IV-8).  The resulting GFPM10M5IQcc constructs were 
successfully purified with reasonable amount of calmodulin (Fig. IV-9), and all showed 
the typical Y-shape as found in myosin 5a with extended head-neck (Fig. IV-10).  Actin 
translocating activity of these constructs was also examined by in vitro motility assay.  
The actin translocation velocities of those constructs were comparable to that of myosin 
10 full-length construct (Fig. IV-11), however, contrary to our expectation, all of the 
GFPM10M5IQcc constructs showed much worse quality of actin translocating activity 
than the previous GFPM10M5cc constructs.  The movements of the actin filaments were 
not smooth, and a significant number of actin filaments dissociated from the myosin-
coated glass surface.  As predicted from this result, neither of the GFPM10M5IQcc 
constructs showed successive movements on actin filaments in the single molecule assay, 
suggesting either that myosin 10 is not a processive motor, or that the neck/coiled-coil of 
myosin 5a is not compatible with the processive movement of myosin 10. 
 
Discussion 
 
It is important to determine the processivity of myosin 10 in order to fully 
understand the physiological process where the molecule is involved.  In this chapter, we 
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directly tested the processivity of force-dimerized myosin 10 chimeras in single molecule 
experiments, and unexpectedly, processive movement was not observed.  The simplest 
explanation of the result is that an individual myosin 10 molecule, even if it is dimerized, 
is not processive.  However, this conclusion cannot explain the reason why myosin 10 
needs the predicted coiled-coil region for the localization at the tips of filopodia (Berg 
and Cheney, 2002).  It is very likely that myosin 10 needs to be dimerized for processive 
movement, because other high duty ratio myosins such as myosin 6 and myosin 7, whose 
predicted coiled-coil regions are very similar to that of myosin 10, become processive 
when they are dimerized (Nishikawa et al., 2002; Rock et al., 2001; Yang et al., 2006). 
Why did the artificially dimerized myosin 10 constructs not show proessive 
movement?  There are several possibilities for the apparent nonprocessive nature of the 
dimerized myosin 10 constructs in the present study.  The first possibility is that the head 
in the rigor state (AM) or in the ADP-bound form (AMD) dissociates spontaneously from 
actin due to the high actomyosin dissociation rates.  As described in Chapter III, the 
dissociation rates of myosin 10 from actin in the presence and the absence of ADP were 
~2 sec-1 and ~1 sec-1, respectively, which are 100~1000-fold faster than those of myosin 
5a and myosin 6. Thus, it is possible that dimeric myosin 10 is mechanistically processive 
(it may take a few steps), but it does not proceed for a long distance because of the 
extremely fast actomyosin dissociation rates. The second possibility is that there is an 
additional regulatory mechanism for making myosin 10 processive after being dimerized. 
The identity of the light chain(s) that actually binds to the neck of myosin 10 in a cell has 
not been completely clarified.  This yet to be identified light chain may be essential for 
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the additional regulation of the processive when it is dimerized.  In fact, the actin 
translocating activities of some myosins are tightly regulated by light chain 
phosphorylation or direct binding of calcium ion to the light chain (Sellers, 2000).  The 
third possibility is that even if dimeric myosin 10 is processive, the molecular mechanism 
of the processive movement may not be the same as that of myosin 5a.  For processive 
movement along actin filaments by hand-over-hand mechanism, the two heads have to be 
coordinated so that the lead head remains on the actin track while the trail head seeks the 
forward binding site, otherwise both heads would dissociate from the actin track before 
proceeding for a long distance even if the motor has a high duty ratio.  Recently, this 
coordination of the two heads has been examined on myosin 5a (Purcell et al., 2005; 
Veigel et al., 2005).  When both heads strongly bind to an actin filament, several 
picoNewtons of the intramolecular strain is posed onto both heads.  The pulling force 
reduces the ADP release rate from the leading head thus prolonging the actin strong-
bound state, whereas the pushing force does not change or even increases the ADP 
release rate from the trailing head.  This increases the probability of the trailing head 
detaching before the detachment of the leading head, thus decreasing the probability of 
both heads simultaneously dissociating from the actin filament before stepping for a long 
distance.  The intramolecular strain mechanism of myosin 10, if any, could be different 
from that of myosin 5a, and this could explain why the qualities of actin filaments 
movement by the M10M5IQcc chimeras in the in vitro motility were much worse than 
those by the M10M5cc chimeras.  It is possible that the motor characteristic and the 
apparently kinked neck structure of myosin 10 are highly specialized for the unique 
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intramolecular strain mechanism for moving processively along the tightly bundled actin 
filaments found in filopodia, but not for single actin filaments found in the cytoplasm.  
Dimeric myosin 10 might processively move inside filopodia by using more than one 
actin filaments of the bundled actin. 
If myosin 10 is simply not as processive as a typical transporter myosin such as 
myosin 5a, how does myosin 10 move cargos for a significant distance in cells? One 
possibility is that dimeric myosin 10 does not have to be highly processive unlike other 
processive myosins, because the dissociation of myosin 10 from the actin filament does 
not significantly facilitate the diffusion of the cargo-myosin 10 complex away from the 
actin filament.  It is proposed that myosin 10 carries β-integrin, a trans-membrane 
molecule, and it is anticipated that the lateral diffusion of the trans-membrane molecules 
is much slower than the diffusion of cytosolic proteins.  Furthermore, it is known that β-
integrin forms a large multi-molecule complex with a molecular mass much greater than 
1 MDa.  Based upon the present results, the time myosin 10 dissociates from actin is less 
than 30 msec (1/13.5 – 1/20 = 24 msec), and it is plausible that the lateral diffusion of the 
molecular complex of greater than 1 MDa within this time is less than the head-neck 
length of myosin 10.  Therefore, it is possible that the cargo does not move away from 
the actin cable during the myosin 10 cross-bridge cycles even if individual myosin 10 
molecules are less processive, thus allowing myosin 10 to transport the membrane bound 
cargos. 
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Future Direction 
 
Although myosin 10 seemed to be nonprocessive in our in vitro single molecule 
experimental condition, it can still be processive in the physiological environment found 
in filopodia of a living cell.  There may be a binding partner(s) of myosin 10 that assists 
the processive movement of dimeric myosin 10 such as dynactin for cytoplasmic dynein 
(King and Schroer, 2000).  Analyzing the step size of myosin 10 in a living cell can be an 
alternative way of testing processivity though it gives less direct evidence.  In live-cell 
imaging, GFP-myosin 10 moves smoothly back and forth inside filopodia, and the GFP 
signals are often very bright, suggesting that a number of myosin 10 molecules are 
clustered while moving.  The strong GFP signals would enable us to trace the movement 
with high temporal (msec) and spatial resolution (nm) (Watanabe et al., 2007).  If 
successive stepwise movement with roughly constant step size (most likely ~36nm if it 
moves like myosin 5a) takes place at least locally while moving to the tip of filopodia, 
then it is likely that individual myosin 10 molecules are actually processive.  If it is 
nonprocessive and thus requires many myosin 10 molecules for the movement towards 
the tip of filopodia, then the stepwise movement will become indistinct due to numerous 
simultaneous interactions of myosin molecules with actin. 
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Figure IV-1. The predicted coiled-coil region of myosin 10. A partial amino acid 
sequence of bovine myosin 10 (Tyr 808 – Pro 979) that contains the predicted coiled-coil 
region is shown. Possible coiled-coil registrations were predicted by COILS 
(www.russell.embl-heidelberg.de/cgi-bin/coils-svr.pl).  The result of running COILS 
three times with windows of 14, 21, and 28 are indicated below the amino acid sequence. 
‘frame’ denotes the predicted position of the heptad repeat for the highest scoring 
window that overlaps each position. ‘prob’ gives a single integer value representation of 
probability (where 0-9 covers the probability 0-1). The stable alpha helix (SAH) and 
three possible coiled-coil registrations are also shown above the amino acid sequence. 
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Figure IV-2. GFPM10M5cc constructs. A. Schematic representation of the constructs. 
The coiled-coil region of mouse myosin 5a was used to force-dimerize bovine myosin 10. 
Abbreviations are: SAH, stable alpha helix; CC, the predicted coiled-coil region of 
myosin 10; M5aCC, the stable coiled-coil region (Leu 908 – Glu 1090). A FLAG epitope 
was attached to the N-terminus of each construct to facilitate purification. B. Amino acid 
sequences at the junctions of the constructs. These constructs were designed not to 
disrupt the coiled-coil registration at the junction. 
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Figure IV-3. Purification of GFPM10M5cc constructs. Each GFPM10M5cc construct 
was purified by FLAG affinity column, and examined by SDS-PAGE. Lane 1, 
GFPM10M5cc1; Lane 2, GFPM10M5cc2; Lane 3, GFPM10M5cc3. Abbreviations are: 
HC, heavy chain; CaM, calmodulin. 
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Figure IV-4. In vitro actin translocating activity of GFPM10M5cc constructs. The 
actin translocating velocities (mean ± s.d.) were 0.039 ± 0.012 µm/sec, 0.23 ± 0.06 
µm/sec, and 0.12 ± 0.05 µm/sec for GFPM10M5cc1, GFPM10M5cc2, and 
GFPM10M5cc3, respectively. 
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Figure IV-5. Processive movement of single GFP-myosin 5a molecules observed by 
TIRFM. A. Schematic representation of a GFP-labeled myosin 5a moving along an actin 
filament processively under the evanescent field (Appendix E). B. A typical recording of 
the processive movement of GFP-myosin 5a molecules. Actin filament was biotinylated 
and labeled with Alexa Fluo 647 phalloidin to be simultaneously observed with GFP 
signals (Appendix E).  Arrowheads indicate the positions of individual GFP-myosin 5a 
molecules moving along an actin filament. 
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Figure IV-6. Rotary-shadowing electron microscopy of GFPM10M5cc constructs. A. 
Electron micrographs of the GFPM10M5cc constructs. The Rotary-shadowing electron 
microscopy was performed by Dr. Katsuhide Mabuchi (Boston Biomedical Research 
Institute). B. Schematic representations of the structures of myosin 5a and the 
GFPM10M5cc constructs inferred from the electron micrographs.  Myosin 5a and myosin 
10 are shown in cyan and green, respectively. 
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Figure IV-7. Converter-neck region of myosin 10 and myosin 5a. A. Sequence 
alignment of the converter/neck regions of myosin 10 and myosin 5a is shown. Highly 
conserved amino acids in the converter regions are colored in orange. Typical amino 
acids found in the IQ motif are colored in yellow. Red arrowheads indicate the junctions 
of myosin 10 and myosin 5a in the redesigned hybrid constructs shown in Figure IV-8. 
Note that the positions of the first IQ and the second IQ of myosin 10 and myosin 5a 
from their converter regions are the same. B. Crystal structure of the motor domain of 
myosin 5a is shown. The 2nd and the 3rd IQ motifs are not shown in this structure. 
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Figure IV-8. GFPM10M5IQcc constructs. A. Schematic representation of the 
constructs. The globular motor domain of myosin 10 was followed by the IQ motifs and 
the coiled-coil region of mouse myosin 5a. A FLAG epitope was attached to the N-
terminus of each construct to facilitate purification. B. Amino acid sequences at the 
junctions of the constructs. Amino acids at the junction of myosin 10 and myosin 5a of 
the hybrid constructs are colored in black. See also Figure IV-7. 
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Figure IV-9. Purification of GFPM10M5IQcc constructs. Each GFPM10M5IQcc 
construct was purified by FLAG affinity column, and examined by SDS-PAGE. Lane 1, 
GFPM10M5IQcc1; Lane 2, GFPM10M5IQcc2; Lane 3, GFPM10M5IQcc3. 
Abbreviations are: HC, heavy chain; CaM, calmodulin. 
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Figure IV-10. Rotary-shadowing electron microscopy of GFPM10M5IQcc 
constructs. A. Electron micrographs of the GFPM10M5IQcc constructs. The Rotary-
shadowing electron microscopy was performed by Dr. Katsuhide Mabuchi (Boston 
Biomedical Research Institute). B. Schematic representations of the structures of myosin 
5a and the GFPM10M5IQcc constructs inferred from the electron micrographs. Myosin 
5a and myosin 10 are shown in cyan and green, respectively. 
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Figure IV-11. In vitro actin translocating activity of GFPM10M5IQcc constructs. 
The actin translocating velocities (mean ± s.d.) were 0.15 ± 0.06 µm/sec, 0.17 ± 0.07 
µm/sec, and 0.11 ± 0.03 µm/sec for GFPM10M5IQcc1, GFPM10M5IQcc2, and 
GFPM10M5IQcc3, respectively. 
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CHAPTER V 
GENERAL DISCUSSION ON THE PHYSIOLOGICAL FUNCTION OF 
 MYOSIN 10 
 
The motor property of myosins - movement directionality and the degree of 
processivity - is thought to reflect the physiological function of a myosin molecule. 
Therefore, understanding motor properties of myosin molecules provides insights into the 
physiological processes where those myosin molecules are involved.  As seen in the 
present study, the plus end-directed movement directionality of myosin 10 is consistent 
with the suggested physiological function of transporting cargos such as VASP or β-
integrin required for the maintenance/elongation of filopodia.  The high duty ratio, the 
long neck (three IQs plus SAH), and the requirement of double-headed structure for the 
localization at the tip of filopodia all support an idea that myosin 10 functions as a 
processive cargo transporter like myosin 5a.  However, unlike myosin 5a, force-
dimerized myosin 10 constructs did not show successive movement along actin filaments 
in the single molecule experiment.  Several possible reasons why we could not observe a 
processive movement were already discussed in the preceding chapter.  Here, assuming 
that dimeric myosin 10 is not as processive as other processive myosins characterized so 
far, how myosin 10 functions as an intrafilopodial cargo transporter is discussed.  
Muscle myosins are the best examples of nonprocessive myosins with very low 
duty ratio.  The low duty ratio enables muscles to contract very efficiently and quickly 
with low consumption of ATP.  For example, the actin translocating velocity of skeletal 
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muscle myosin is 5~10 µm/sec, while the maximal actin activated ATPase rate is 
~20/sec.  This means that skeletal muscle myosins translocates an actin filament 250~500 
nm / ATP.  [The distance is far greater than the structural dimension of the protein, and 
has been a paradox.  The concept of duty ratio provides an explanation for the step size 
paradox. The unitary step size of skeletal muscle myosin is calculated as (5~10 µm/sec) / 
(~20 /sec) × duty ratio (0.01~0.02) = 2.5~10 nm, which is in the range of the structural 
dimension of the protein.]  Contrary to those low duty ratio myosins, high duty ratio 
myosins have small step distances per ATP (e.g. ~20 nm/ATP for myosin 5a), and the 
ATPase rate needs to be highly increased for attaining an actin translocating velocity 
comparable to that of muscle myosins.  The same calculation gave ~13 nm /ATP for 
myosin 10 (M10IQ1), which is within the structural dimension of the protein.  This is 
another indirect evidence of myosin 10 as a high duty ratio motor, and strongly suggests 
that the nonprocessive nature of myosin 10 is qualitatively different from those of other 
highly nonprocessive muscle myosin motors characterized so far.  Therefore, at least the 
apparent nonprocessive nature of myosin 10 does not seem to attain higher actin 
translocation efficiency. 
Myosin 10 molecules seem to be clustered when they move inside filopodia.  A 
simple explanation is that, because individual myosin 10 molecules are nonprocessive, 
multiple molecules are required to be able to function as a cargo transporter.  If so, is 
there any advantage in having a nonprocessive motor instead of a processive motor for 
the cargo transport in filopodia?  Myosin 10 has been suggested to transport β-integrin, 
which associates with the extracellular substrates.  Thus, one possibility is that a large 
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magnitude of force is required for the transport of myosin 10-dependent cargo inside 
filopodia, and thus multiple myosin 10 molecules are required to work in concert to 
generate sufficient forces.  If myosin 10 is highly processive, and thus binds strongly to 
actin in the AMD form after translocating along actin, this strong binding itself would 
interfere with the translocation by other myosin molecules.  The extremely low affinity of 
myosin 10 to actin in the presence and the absence of ADP (AMD and AM forms) may 
be important for minimizing the resistance while maximizing the number of actomyosin 
crossbridges for force generation.  This is different from typical nonprocessive muscle 
myosins whose primary advantage are to efficiently and quickly translocate actin 
filaments by minimizing the number of actomyosin crossbridges.  For example, only 3~6 
crossbridges out of ~300 crossbridges found in each half of the myosin thick filament 
maintain contact between the thick filament and thin filament in skeletal muscle because 
of the low duty ratio (0.01~0.02).  Therefore, it is possible that the processivity of myosin 
10 is customized for cargo transport that demands strong force. 
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 CHAPTER VI 
FINAL REMARKS 
- Molecular mechanism behind directionality and processivity - 
 
The ultimate goal of this study is to clarify the molecular mechanism of how 
myosin motors convert the chemical energy of ATP into mechanical work. Is the 
fundamental mechanism of biological machines like molecular motors different from that 
of the manmade machines such as automobiles?  If so, how exactly are they different?  If 
not, how well can we describe molecular mechanism with analogies to the manmade 
machines?  It seems intuitive that biological machines and artificial machines are 
different from each other.  The output of artificial machines is usually exactly what we 
expect. This is because of the large energy input used for operating these machines.  The 
output of biological machines, however, is typically rather stochastic.  For example, 
myosin 5a, a plus end-directed actin-based processive molecular motor, takes variable 
step sizes (~36 nm on average) while it moves along the actin filament towards the plus 
end, and, strikingly, it sometimes steps backward (Mehta et al., 1999).  This is because of 
the low energy input for operating molecular motors.  Since the free energy released by 
ATP hydrolysis is just ~20 kBT under typical physiological conditions, the output of 
biological machines is easily affected by the thermal energy in the order of kBT.  How 
can such biological molecular machines maintain life so successfully?  Such stochastic 
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output of individual biological machines may be the key to understanding the underlying 
logic used in life system as a whole. 
Molecular motors such as myosin, kinesin, and dynein are highly accessible 
simple models from which we can learn the general strategy of biological systems, 
because the output – the motor activity – is readily measurable by performing the 
transient kinetics assay, the in vitro motility assay, and the single molecule assay, etc.  
For clarifying the molecular mechanism, it is quite beneficial to compare one molecular 
motor to the other with a different motor property.  Fortunately, there are a number of 
naturally occurring molecular motors whose motor properties are different from one 
another.  Many of those molecular motors have been thoroughly characterized 
biochemically and biophysically, and crystal structures of some of them are already 
available.  Further extensive characterization of other yet to be analyzed molecular 
motors will help us grasping the detailed picture of how these molecular motors work.  
The present study on myosin 10 provided a unique example of a myosin motor showing 
nonprocessive nature while retaining a high duty ratio.  Combining results obtained in 
this study with currently available experimental results with other myosin and kinesin 
molecules, I will discuss the molecular mechanism behind the directionality and the 
processivity of the myosin motors. 
 
The lever-arm hypothesis 
The lever-arm hypothesis has become the textbook norm for explaining how a 
myosin molecule translocates relative to an actin filament (Fig. VI-1).  Briefly, the 
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hypothesis claims that small conformational changes that take place in the motor core 
domain associated with the ATP hydrolysis cycle are amplified by the swing of the light 
chain-bound rigid neck (power stroke) to generate a unitary displacement.  The angular 
change of the neck region associated with the ATPase cycle has been actually observed in 
muscle (Irving et al., 1995).  The swing-like conformational change of the neck has also 
been supported by cryoelectron microscopic studies (Jontes et al., 1995; Whittaker et al., 
1995), and by the X-ray crystallographic studies (Dominguez et al., 1998; Houdusse et 
al., 2000; Smith and Rayment, 1996). 
 
Movement directionality 
The movement directionality of myosins has been explained by the angle of the 
neck with respect to the motor core domain.  The minus end-directed motility of myosin 
6 seems to be attributed to its uniquely positioned neck (Appendix Fig. F-1).  The facts 
that modification or truncation of the redirected neck successfully converted the minus 
end-directed motility into the plus end-directed motility (Bryant et al., 2007; Park et al., 
2007)(Appendix F), and that the plus end-directed motility of myosin 1 (MyoE) was 
reversed simply by rotating the direction of the neck ~180o using protein engineering 
(Tsiavaliaris et al., 2004) seem to strongly support the hypothesis. To further test if the 
apparently redirected neck of myosin 6 is responsible for the minus end-directed motility, 
we generated a number of chimeric myosin constructs comprised of parts from myosin 5a 
and myosin 6 (Appendix F). 
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In the case of microtubule-based kinesin motors, the unidirectional processive 
movement on a microtubule was first explained by the neck linker docking model.  In this 
model, the microtubule-unbound head of dimeric kinesin is pushed towards the plus end 
direction by the docking of the neck linker to the motor core induced by the 
conformational change associated with the binding of ATP to the microtubule-bound 
head of kinesin (Fig. VI-2A) (Rice et al., 1999).  The ‘neck linker docking’ corresponds 
to the ‘power stroke’ of myosin, and this model was highly analogous to the lever arm 
hypothesis of myosin.  Rice et al. recently measured the free energy released by the neck 
linker docking of kinesin (Rice et al., 2003), and found that the free energy (1~2 kBT) 
was too small to explain the maximal work done by dimeric kinesin, ~14kBT (~7 pN x 8 
nm step size).  Although the free energy released by the ‘power stroke’ of myosins has 
not been reported on any myosin, it is possible that the free energy released by the ‘power 
stroke’ is not sufficient to account for the work done by a myosin molecule (e.g. 
16~17kBT for myosin 5a).   
 If the translocation is not provided by the ‘power stroke’, how do motor proteins 
move unidirectionally? It has been known that a dimeric kinesin molecule moves along 
microtubule in a hand-over-hand manner with an 8 nm step size towards the plus end, and 
that an external pulling force on a kinesin molecule against the direction of the movement 
increases the frequency of backward 8 nm step with ATP consumption (Carter and Cross, 
2005).  Recently, Taniguchi et al. have thoroughly examined the mechanical kinetics and 
thermodynamics of the movement of dimeric kinesin (Taniguchi et al., 2005).  They 
found that the forward/backward stepping asymmetry of kinesin is generated by ~6 kBT 
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of entropic asymmetry, but not enthalpic asymmetry (~0.1 kBT).  This entropic 
asymmetry is more than three times greater than the free energy released by the neck 
linker docking (1~2 kBT).  Based on these results, Taniguchi et al. proposed that the 
direction of the movement of kinesin is entropically biased to the plus end direction due 
to the neck linker docking (1~2 kBT) and the steric compatibility between the motor 
domain and microtubule (4~5 kBT) because of their polar structures (Taniguchi et al., 
2005) (Fig. VI-2B).  Although similar thermodynamic examination has not been reported 
on any myosin, it is possible that the unidirectional motility of myosin is also explained 
by the entropic asymmetry found in kinesin.  The apparent swing-like conformational 
change of the C-terminal neck of a myosin molecule associated with the ATP hydrolysis 
cycle might be important for generating the entropic asymmetry. 
 
Processivity 
 The successive movement of double-headed processive myosins has been 
explained by the hand-over-hand model based on the lever-arm hypothesis (Fig. VI-3), 
and recent single molecule studies strongly support the model (Asbury et al., 2003; 
Kaseda et al., 2003; Okten et al., 2004; Warshaw et al., 2005; Yildiz et al., 2003; Yildiz 
et al., 2004a; Yildiz et al., 2004b).  For processive movement by the hand-over-hand 
mechanism, one of the two heads has to remain on the track until the other head binds to 
the forward binding site.  High duty ratio (>0.5) of the processive motors characterized so 
far partially explains how the processive movement can be achieved, however, the high 
duty ratio itself does not explain the long distance processive movement, because the two 
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heads have to be coordinated.  If not coordinated, both heads would simultaneously 
detach from the track before traveling for a long distance.  For kinesins, the coordination 
between the two heads is achieved by a force between the two heads (5~15 pN) (Rice et 
al., 2003), which is developed when both heads bind strongly to a microtubule.  The 
intramolecular strain in turn modulates the rates of ATP binding, ADP release, and 
phosphate release so that the dissociation of the trail head from the microtubule track 
precedes the ATP binding to the lead head (Cross, 2004; Valentine and Gilbert, 2007).  
Mutagenesis and chemical crosslinking studies suggest that the neck linker plays an 
important role for the coordination of the two heads of kinesin motors (Case et al., 2000; 
Tomishige and Vale, 2000). 
The coordination between the two heads by the intramolecular strain-dependent 
mechanism was also reported in myosin 5a (Purcell et al., 2005; Veigel et al., 2005). 
Several picoNewtons of the intramolecular force is estimated to be induced when both 
heads bind to actin.  The pulling force on the lead head reduces the ADP release rate, 
whereas the pushing force on the trail head does not affect or even enhances the ADP 
release rate.  This reduces the probability of simultaneous dissociation of both heads from 
actin before traveling for a long distance. The apparently nonprocessive nature of the 
dimerized myosin 10 constructs (Chapter IV) was a surprise. However, this may indicate 
that the inter-head coordination mechanism found for myosin 5a may not always apply to 
other processive myosins.  A recent study reported that the intramolecular strain-
dependent coordination mechanism of myosin 6 is different from that of myosin 5a 
(Sweeney et al., 2007).  Knowing the variations of the inter-head coordination 
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mechanism is beneficial for better understanding the molecular mechanism behind 
processivity. Future studies will shed more light on the underlying molecular mechanism 
of processivity. 
 
Remaining enigma 
Myosin 9b - a single-headed processive motor – The architecture of the N-terminal 
motor domain of myosin is highly conserved among the superfamily, suggesting that 
myosin molecules share a fundamentally similar molecular mechanism.  Thus, it is quite 
natural to assume that the same molecular mechanism is shared among the myosin 
supterfamily. 
The lever-arm hypothesis seems to be successful in explaining the molecular 
mechanism of directionality and processivity of myosin in general.  The processive 
movement of myosin 5a can be explained by its double-headed structure with hand-over-
hand mechanism.  Likewise, the processive reversed end-directed motility of myosin 6 
can be explained by a hand-over-hand mechanism with redirected necks in its double-
headed structure.  However, the lever-arm hypothesis cannot explain the molecular 
mechanism of a single-headed, unidirectional processive myosin – myosin 9b (Inoue et 
al., 2002; Post et al., 2002).  Like other myosins, myosin 9b has an N-terminal globular 
motor core domain followed by a converter region and a neck region to which four light 
chains bind.  Thus, structurally, myosin 9b is not exceptional when compared to other 
myosins.  However, it can somehow move processively along actin filament 
unidirectionally without dimerizing or attaching to a scaffold (Nishikawa et al., 2006). 
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Obviously, the molecular mechanism cannot be explained by the cyclical conformational 
change of the lever-arm.  How does myosin 9b work?   
A clue to this question comes from an unconventional kinesin, KIF1A, another 
example of a single-headed processive motor whose movement mechanism cannot be 
explained by the conformational change of the distal region such as neck linker docking.  
The overall structure of the motor domain of KIF1A is very similar to that of 
conventional kinesin.  For the processive movement, the motor domain has to remain 
associated with the microtubule.  The single-headed processive movement of KIF1A has 
been explained by the lysine-rich microtubule-binding site in the motor core domain 
termed ‘K-loop’.  The K-loop is thought to maintain weak binding of the motor core to 
the microtubule while moving diffusively along the microtubule towards the plus end 
(Okada and Hirokawa, 2000).  A recent study has proposed a molecular mechanism of 
how a single-headed KIF1A molecule moves towards plus end by diffusional search on 
the microtubule (Okada et al., 2003). 
The loop-2 of myosin 9 contains a significantly large insertion when compared to 
other classes of myosin.  Like K-loop of KIF1A, the loop-2 might play a similar role for 
maintaining affinity to actin filament during the movement.  Although the molecular 
mechanism of how single-headed myosin 9b moves processively along actin filament 
towards minus end has not been fully understood, it is less likely that the fundamental 
molecular mechanism of myosin 9b is completely different from those of other myosins 
characterized so far.  The fact that the monomeric myosin 9b can still function as a 
processive motor suggests that hand-over-hand with double-headed structure is not 
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required for a motor to be processive, although it may be advantageous to have a 
coordinated double-headed structure for processive movement.  Further studies on 
myosin 9 will be beneficial for unraveling the fundamental molecular mechanism of how 
the movement directionality and the processivity of myosins are determined.  
 
Challenge against the lever-arm hypothesis - The lever-arm hypothesis predicts that the 
displacement and the velocity of myosin are proportional to the length of the neck 
domain.  Some researchers have shown that the actin translocating velocity is indeed 
proportional to the length of the neck (lever-arm) (Anson et al., 1996; Uyeda et al., 1996), 
however, others have shown that the length of the neck does not affect the velocity 
(Perreault-Micale et al., 2000; Trybus et al., 1999).  In the present study on myosin 10, 
we also found that the actin tranlocating velocity was not affected by the truncation of the 
neck (Table II-1).  In collaboration with the Yanagida laboratory (Osaka, Japan), we 
further tested if the dimeric structure of myosin 5a with the long neck (23 nm) is essential 
for the processive movement with the large step size (~36 nm). Surprisingly, a single-
headed myosin 5a construct still developed multiple large (~32 nm) steps successively 
(Watanabe et al., 2004), and the step size was not affected by the truncation of the neck 
(Tanaka et al., 2002) [(Although the results are still controversial (Sakamoto et al., 2003; 
Sakamoto et al., 2005)].  The results imply that the molecular mechanism of the 
processive movement is fundamentally similar among all the processive motors 
irrespective of their oligomeric states.  It seems to be true that the swing-like 
conformational change of the neck of the myosin molecule associated with the ATP 
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hydrolysis cycle do occur. However, whether actin translocation is directly powered by 
the so-called ‘power stroke’ of the neck (lever-arm) is still very much an open question. 
 
The molecular mechanism of myosin behind directionality and processivity 
Lastly, I would like to propose the following regarding the molecular mechanism 
behind the directionality and processivity of myosin. 
 
The free energy of ATP is used for establishing the actin weak-binding state of the 
motor core, and for generating entropic asymmetry for the forward step and the 
backward step – For the diffusional search on actin, the motor core domain has to be in 
the actin weak-binding state.  This requires energy because the motor domain of myosin 
usually strongly binds to actin in the presence of ADP or in the absence of nucleotides.  
The entropic asymmetry may be generated by the swing-like conformational change of 
the neck and/or the steric compatibility between the motor core and actin due to their 
polar structures. It is important to consider that the entropic asymmetry is generated by 
using the free energy of the ATP hydrolysis, but not simply by the apparent structural 
binding compatibility.  If the entropic asymmetry is generated merely from the apparent 
structural factors, the model then calls for ‘Maxwell’s demon’ – the motors move along 
actin without consuming ATP, which violates the second law of thermodynamics.  Even 
if the dissociation rate of the motor domain from actin is very slow in the absence of 
ATP, the motor domain can spontaneously detach from actin due to the thermal energy.  
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Movement directionality can be determined solely by the motor core region - Although 
lines of evidence now suggest that the positioning of the neck with respect to the head 
plays a major role in dictating the minus end-directed movement of myosin 6, this cannot 
explain the minus end-directed motility of myosin 9b.  Myosin 9b does not have an 
insertion in the neck that changes the position of the neck, and even more importantly, it 
does not have to be dimerized or attached to a scaffold to be processive.  In the case of 
kinesin, disruption of the neck linker does not affect the plus end-directionality (Case et 
al., 2000), suggesting that the motor core itself is capable of establishing the entropic 
asymmetry for the forward step and the backward step. In myosin 9b, loop-2 may be 
involved in determining the movement directionality, and may play a primary role in 
determining the minus end-directed motility. It is possible that several factors (e.g. loop-
2, a redirected neck, etc) concurrently contribute to establishing the entropic asymmetry 
along actin, and that the balance of those contributions is different among the myosin 
superfamily. 
 
Processivity is simply determined by the affinity of the motor core region to actin 
during the actin weak-binding state – The double-headed structure found in many 
processive myosins may not be fundamentally essential for the successive movement 
along actin.  Having two heads may simply increase the affinity of the motor domain to 
actin.  We actually found that a double-headed myosin 5a with truncated neck and a 
single-headed myosin 5a are capable of developing multiple large steps successively 
along actin (Tanaka et al., 2002; Watanabe et al., 2004).  It should be emphasized that 
108
most single molecule experiments that demonstrated the hand-over-hand mechanism 
have been done under low ATP conditions where ATP binding limited the entire ATPase 
cycle.  Under such conditions, one of the two heads is forced to bind actin, thus 
increasing the chance of observing the hand-over-hand movement.  Consistent with this 
concern, binding of only one of the two heads, but not of both heads, of dimeric myosin 
5a to actin was predominantly observed under physiological concentrations of ATP 
(Walker et al., 2000). 
At this point, it is not clear how the globular motor core generates the entropic 
asymmetry along actin filament by using the free energy of ATP.  Additional studies are 
required for establishing a better model that is capable of explaining the molecular 
mechanism of directionality and processivity of all myosin motors. 
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Figure VI-1. The lever-arm hypothesis. The motor domain of myosin, the converter 
region, and the neck region (lever-arm) are colored in green, blue, and red, respectively. 
In this hypothesis, small conformational changes in the motor core domain associated 
with the ATP hydrolysis cycle are thought to be converted into the swing-like motion of 
the C-terminal neck region (power stroke) to generate a unitary displacement. 
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Figure VI-2. Unidirectional processive movement of dimeric kinesin along 
microtubule. A. Unidirectional processive movement of kinesin along microtubue by 
neck linker docking mechanism. Inset. The crystal structure of dimeric kinesin (3KIN). 
The motor core domain (green), neck linker region (blue) and a partial coiled-coil region 
(red) are shown. B. Unidirectional processive movement of kinesin along microtubue 
driven by entropic asymmetry. The motor core domain, neck linker region, and the 
coiled-coil region are colored in green, blue, and red, respectively. Microtubule track is 
shown in pink and purple. ‘ + ’ and ‘-‘ indicate the polarity of microtubule. 
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Figure VI-3. Processive movement of myosin 5a by hand-over-hand mechanism. 
Unidirectional processive movement of myosin 5a along actin driven by hand-over-hand 
based on the lever-arm hypothesis. The globular motor domain, converter, the 
neck/coiled-coil region, and calmodulins bound to the neck are colored in green, blue, 
red, and orange, respectively. Actin track is shown in pale red. ‘ + ’ and ‘ - ’ indicate the 
polarity of actin. 
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APPENDIX A 
POLARITY-MARKED ACTIN FILAMENT 
 
A simple procedure for preparing polarity-marked actin filaments was developed in the 
present study (Chapter II). Here, sequential images of the movement of the polarity-
marked actin filaments on a myosin 5a-coated glass surface (Fig. A-1) and on a myosin 
6-coated glass surface (Fig. A-2) are shown. Myosin 5a and myosin 6 were used as 
controls for plus end-directed motility and minus end-directed motility, respectively. As 
expected, almost all the polarity-marked actin filaments moved with the 
tetramethylrodamine-labeled tips (colored in red) leading the movement on a myosin 5a-
coated glass surface, whereas almost all the polarity-marked actin filaments moved with 
the tetramethylrhodamine-labeled tips trailing the movement on a myosin 6-coated glass 
surface. Actin filaments without the tetramethylrhodamine cap were also observed.  The 
results confirmed the successful polarity-labeling of actin filaments. 
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Figure A-1. Sequential images of the polarity-marked actin filaments moving on a 
myosin 5a-coated glass surface (M5aIQ2). 
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Figure A-2. Sequential images of the polarity-marked actin filaments moving on a 
myosin 6-coated glass surface (M6IQ1). 
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APPENDIX B 
THE MEANING OF RATE CONSTANTS 
 
Enzymatic reactions are stochastic events.  The distribution of the reaction time (time 
required for the completion of a single reaction) is best explained by a Poisson 
distribution.  This is easily confirmed empirically – a reaction time course always follows 
an exponential path.  Thus, the distribution of the probability of reaction time is described 
as 
                                 
From this probability function, the average reaction time is calculated. 
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For example, the reaction rate of “5/sec” means that it takes 0.2 seconds to complete each 
reaction on average, or five reactions occurs in a second on average.  Since the rate 
constants depend on an experimental condition, especially on the temperature, care has to 
be taken for comparison of rate constants obtained from different procedures. 
 
117
APPENDIX C 
ENZYME KINETICS 
 
The kinetic mechanism of myosin ATPase reaction 
In general, the reaction scheme of actomyosin ATPase can be described as follow. 
 
 
Abbreviations: A, actin; M, myosin; T, ATP; D, ADP; P, phosphate. 
Equilibrium constants (K) are defined here as k+/k- (ex. K’1 ≡ k’+1/k’-1). 
 
The combination of individual rate constants determines the unique motor property of 
myosin.  Experimental methods for obtaining those rate constants (and the equilibrium 
constants) with mathematical explanations are described below. 
 
Actin-myosin binding kinetics  
The motor domain of myosin tightly binds to actin in the presence of ADP or in the 
absence of nucleotide.  The fraction of the tightly actin-bound reaction intermediate 
determines the duty ratio of the molecule.  The reaction scheme of actin-myosin binding 
in the absence of nucleotide or in the presence of ADP is described as 
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The fluorescence intensity of pyrene-actin decreases upon binding of myosin.  Thus the 
formation of AM or AMD can be followed by simply monitoring the fluorescence 
intensity of pyrene.  Light scattering measurement is also employed as an alternative 
method to monitor the binding of myosin to actin – the intensity increases upon binding 
of myosin to actin.  The reaction time course of the AM formation follows a single 
exponential path, and the apparent rates are explained by 
 
                                         
 
This is derived from the following calculation. 
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The exponent gives apparent rate constants (kobs) at given actin concentrations.  By 
plotting the apparent rates against the actin concentrations, k-12 and k+12 are obtained from 
the slope and from the y-intercept, respectively. 
   
 
 
If myosin is premixed with pyrene-actin first and rapidly mixed with excess amount of 
unlabeled actin, the apparent rate constant of the pyrene fluorescence increment would 
become k+12.  This experiment is often performed for determining k+12, because, for many 
myosins, k+12 (and also k+10) is too small to be determined precisely from the y-intercept.  
By performing the same experiment described above in the presence of saturating ADP, 
k+10 and k-10 will be determined. 
 
Nucleotide binding to myosin 
Nucleotide (ATP and ADP) binding to myosin is a two-step process.  First, nucleotide 
quickly binds to (also quickly dissociates from) the active site of myosin and forms a 
collision complex (shown in parentheses in the reaction scheme).  This first step is 
thought to be in a rapid equilibrium, followed by the second, a relatively slow 
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isomerization step.  The nucleotide binding process is visualized by using fluorescently 
labeled nucleotide analogs such as mant-ATP (or ADP).  The fluorescence intensity of 
those nucleotide analogs increases several-fold due to isomerization of the motor domain 
upon binding to the nucleotide.  The reaction schemes of the nucleotide binding are as 
follows.  Mathematically, they are all treated in the same way. 
 
           
 
For mathematically describing the ATP binding to myosin in the absence of actin, the 
followings are first defined. 
 
By these definitions, the rate of MT formation can be written as 
 
By solving this differential equation, we obtain the time-dependent function of MT. 
121
  
The exponent is an apparent rate constant (kobs) that will be obtained in an actual 
experiment.  The kobs is ATP dependent and is reminiscent of the Michaelis-Menten 
equation. 
 
 
 
 
If 1/K1 >> [T], 
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This explains the initial slope of the ATP-dependent kobs curve.  Pyrene-labeled actin is 
also used for monitoring AMT formation.  Actin binds weakly to myosin at the AMT 
state, and the fluorescence intensity of pyrene increases during the formation of this 
weakly-bound actomyosin state. 
 
Light scattering measurement is performed for monitoring ATP-induced actomyosin 
dissociation.  For most myosins characterized so far, ATP-induced actomyosin 
dissociation (k+8) is a quick process, and thus the ATP-dependent kobs curve is 
indistinguishable from that obtained by pyrene-actin.  This was also the case for myosin 
10 (see Chapter III).  If k’+2 > k+8, however, the maximum kobs value obtained from light 
scattering experiment represents k+8 + k-8[A], instead of k’+2 + k’-2. 
 
ATP hydrolysis 
In general, the ATP hydrolysis step of myosin is a relatively quick, reversible process as 
if myosin is chewing up ATP.  This step is simply described as 
                            
The ratio of k+3 to k-3 (or k’+3 to k’-3) determines the fraction of apparently hydrolyzed 
ATP at this step.  It is called the burst size (B). 
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The burst size can be directly determined by using [γ32P]ATP.  After mixing myosin with 
substoichiometric concentration of [γ32P]ATP, the mixture is quickly mixed with strong 
acid to inactivate myosin at various time, and the released γ32P is titrated.  If the 
hydrolysis rate (k+3) and the ATP binding rate under the experimental condition 
(K1k+2[T]) are faster than the phosphate release rate (k+4), the time-dependent ATP 
hydrolysis profile is explained by two-phase exponential kinetics.  The first phase 
represents the rate of ATP binding, and the second phase represents phosphate release.  
The fraction of the amplitude of the fast phase represents the burst size.  Due to the use of 
substoichiometric concentrations of ATP, ATP binding cannot be regarded as a pseudo 
first order reaction.  However, for a practical purpose, this can be ignored for determining 
the burst size. 
 
The sum of the forward rate and the backward rate (k+3 + k-3) is determined from the 
maximum apparent ATP hydrolysis rate under saturating ATP condition if k+2 > (k+3 + k-
3).  However, this is not practical in general, because the signal to noise ratio plummets 
with higher concentrations of [γ32P]ATP.  Using higher concentration of myosin would 
compensate the effect, however, this is not practical for determining the maximum kobs, 
either.  There is a relatively conserved tryptophan residue at the tip of the relay helix of 
myosin head (Fig. F-8), and the fluorescence intensity of this tryptophan increased at the 
post hydrolysis state.  Thus, measurement of the tryptophan fluorescence intensity has 
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been an alternative way of monitoring the formation of the MDP state.  Under low 
concentrations of ATP (K1k+2[T] << (k+3 + k-3)), the apparent ATP-dependent kobs curve 
follows K1k+2[T] because the rate is limited by ATP binding.  If the rate of ATP binding 
well exceeds the ATP hydrolysis rate under saturating ATP, k+2 > (k+3 + k-3), we can 
ignore the ATP binding step as if the whole reaction just starts from the MT state.  Thus 
the differential equation describing the formation of MDP can be simplified as follows, 
and the solution will be 
 
At intermediate concentrations of ATP where K1k+2[T] is comparable to (k+3 + k-3), the 
reaction cannot be simplified as a single step reaction.  The whole reaction should be 
described as a sequential reaction (M ↔ MT ↔ MDP), and the formation of MDP should 
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not be explained by single exponential kinetics.  However, single exponential fittings are 
usually performed to obtain the kobs values at intermediate ATP conditions, and the 
maximum kosb (k+3 + k-3) is practically estimated by curve fiting using the Michaelis-
Menten equation, although these are theoretically not correct.  By knowing the burst size, 
the k+3 and k-3 values are determined individually. 
 
Inorganic phosphate release 
Phosphate release from the active site of myosin is directly monitored by using coumarin-
labeled phosphate binding protein (MDCC-PBP).  Phosphate binding to MDCC-PBP is 
very quick (136 µM-1sec-1) and the fluorescence intensity of coumarin increases ~5-fold 
upon phosphate binding.  For measuring the phosphate release rate, myosin and ATP are 
first mixed and aged for ensuring the complete ATP binding.  This time duration is 
determined by the ATP binding rate under the experimental condition employed.  Then 
the MT–MDP mixture is quickly mixed with MDCC-PBP with or without actin.  The rate 
of the phosphate release is determined by monitoring the rate of fluorescence intensity 
increase of MDCC-PBP.  The phosphate re-binding rates (k-4 and k’-4) are often ignored 
because they are very small compared to the release rates.  This fact is easily confirmed 
by measuring the steady-state ATPase activity of myosin in the presence of excess 
amount of phosphate – the ATPase activity is barely inhibited by 1~2 mM of phosphate. 
 
In the absence of actin, the phosphate release step is described as follows, and thus the 
release of phosphate is explained by a simple exponential kinetics. 
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k+4 is directly determined by the apparent rate of the phosphate release in a single 
experiment.  (k+4 is also determined from the apparent rate of the second exponential in 
the burst size determination experiment described above.) 
 
In the presence of actin, the reaction scheme is described as a parallel reaction. 
                                 
 
The description of the rate of the actin-dependent phosphate release process is analogous 
to that of nucleotide binding rates.  (Caution: the reverse rate (k’-4) is ignored, and the K9 
is defined as k+9/k-9.) 
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Thus, the overall phosphate release rate is described as follow (see below for a parallel 
reaction). 
 
As in the case of nucleotide bindings, under low concentration of actin ([A]<<K9), the 
slope can be simply described as k’+4 / K9, which is analogous to “K1k+2“ for the ATP 
binding kinetics.  K9 and K8 are usually regarded as rapid equilibrium constants. 
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Parallel reaction 
The time-dependent function of the formation of “b” is derived as follow. 
 
                     
 
The apparent rate of the formation of “b” becomes (ka + kb).
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 APPENDIX D 
KINETICS SIMULATION 
 
The objective of performing enzyme kinetic analysis of myosin 10 is to estimate 
the duty ratio – the fraction of strongly actin-bound intermediates (AMD and AM).  
Based on the rate constants and equilibrium constants obtained in the current study, the 
fractions of the reaction intermediates were estimated by computer simulation described 
below.  The fraction of AMDP at steady-state determines the steady-state ATPase 
activity.  Under the saturating ATP condition, the ATP binding rate reaches the 
maximum rate (k’+2 ~ 800 sec-1).  The ATP regeneration system (pyruvate kinase + 
phosphoenolpyruvate) eliminates free ADP, thus the ADP re-binding process can be 
ignored.  In the presence of actin, the ATPase reaction scheme of myosin 10 can be 
simplified as bellow. 
 
 
 
This reaction scheme is expressed as follows in STELLA v8.1.1 software (iseesystems, 
Lebanon, NH).  The simulation was performed by Runge-Kutta 4th approximation with 
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calculation time interval of 50 µsec. Halving and doubling the calculation time interval 
did not affect the result. 
 
AM(t) = AM(t - dt) + (R5 - R1) * dt 
INIT AM = 1 
 
INFLOWS: 
R5 = k'5*AMD 
OUTFLOWS: 
R1 = K'1k'2T*AM 
AMD(t) = AMD(t - dt) + (R4 - R5) * dt 
INIT AMD = 0 
 
INFLOWS: 
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R4 = k'4*AMDP 
OUTFLOWS: 
R5 = k'5*AMD 
AMDP(t) = AMDP(t - dt) + (R9 - R4) * dt 
INIT AMDP = 0 
 
INFLOWS: 
R9 = ka9*actin*MDP-kd9*AMDP 
OUTFLOWS: 
R4 = k'4*AMDP 
AMT(t) = AMT(t - dt) + (R1 - R8) * dt 
INIT AMT = 0 
 
INFLOWS: 
R1 = K'1k'2T*AM 
OUTFLOWS: 
R8 = kd8*AMT-ka8*actin*MT 
MDP(t) = MDP(t - dt) + (R3 - R9) * dt 
INIT MDP = 0 
 
INFLOWS: 
R3 = kf3*MT-kr3*MDP 
OUTFLOWS: 
R9 = ka9*actin*MDP-kd9*AMDP 
MT(t) = MT(t - dt) + (R8 - R3) * dt 
INIT MT = 0 
 
INFLOWS: 
R8 = kd8*AMT-ka8*actin*MT 
OUTFLOWS: 
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R3 = kf3*MT-kr3*MDP 
P(t) = P(t - dt) + (RP) * dt 
INIT P = 0 
 
INFLOWS: 
RP = k'4*AMDP 
actin = 10 
K'1k'2T = 800 
k'4 = 100 
k'5 = 23 
ka8 = 100 
ka9 = 154 
kd8 = 10000 
kd9 = 10000 
kf3 = 184 
kr3 = 216 
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APPENDIX E 
TOTAL INTERNAL REFLECTION MICROSCOPE (TIRFM) 
 
The prism-type total internal reflection microscope was built and used in the 
current study.  The advantage of the prism-type TIRFM is its wider observation area with 
lower background.  The disadvantage is the limitation of the thickness of the samples (the 
sample thickness must be smaller than the working distance of the objective lens).  For 
the in vitro single molecule experiment described in Chapter IV, the thickness limitation 
does not pose any problem.  The schematic representation of the TIRFM setup employed 
in this study is shown below. 
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 The evanescent field 
The total internal reflection microscope (TIRFM) utilizes the evanescent field for 
illuminating fluorescent samples.  The evanescent field is easily obtained by letting the 
incident light totally reflect on the glass–solution interface.  Since its intensity 
exponentially decays from the glass surface, the evanescent field typically illuminates 
only 50 ~ 200 nm from the glass surface.  Therefore, individual fluorescent sources near 
the glass surface are visualized with a very high signal-to-noise ratio. 
 
    Why does the evanescent field “leak” into the solution, although the incident light 
totally reflects on the glass-solution interface?  Why does it illuminate such a shallow 
depth from the interface? 
 
    Light is described as an electromagnetic wave.  When the incident light reflects on the 
glass-solution interface, two electromagnetic fields – one for the incident light and the 
other for the reflected light - exist in the glass side.  The electromagnetic fields are not 
vanished suddenly on the solution side.  Thus the energy of the electromagnetic fields 
leaks, but it no longer propagates through the solution side because the energy of the 
evanescent field does not flow perpendicular to the reflection surface.  This leak of the 
energy of the electromagnetic fields is called evanescent field. 
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    The intensity of the evanescent field exponentially decays with perpendicular distance 
(z) from the reflection interface: 
                                                       
where 
                                            
 
Parameter λ is the wavelength of the incident light in vacuum.  ng and ns are the reflective 
indexes of the glass and the solution, respectively.  θ is the incident angle (measured from 
the normal to the interface). 
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APPENDIX F 
MOLECULAR MECHANISM OF THE DETERMINATION OF MYOSIN 
DIRECTIONALITY 
 
Although the results described in this section are worth mentioning in the main 
body of this thesis, they are treated as an appendix because the contents are not directly 
related to the study on myosin 10.  The results provide important insights into how the 
movement directionality of myosin is determined. 
 
Introduction 
 
Movement directionality of motor proteins is one of the most important 
characteristics that define their distinct physiological functions in a cell.  As mentioned in 
Chapter II, the plus end-directed movement directionality of myosin 10 suggests the 
possible physiological function as a plus end-directed transporter inside filopodia. 
What determines the movement directionality of myosins?  Myosin 6 was the first 
myosin identified as a minus end-directed myosin, and it is proposed that the unique 53-
amino acid insertion in the neck region of the molecule is responsible for the minus end-
directed movement by acting as a reversed lever (Wells et al., 1999).  The hypothesis was 
convincing because only class 6 myosins retain the unique insertion in the neck, and it 
137
was the sole myosin identified as a minus end-directed myosin when it was first 
characterized.  The neck region of myosin 6 turned out to be actually redirected by ~120o 
relative to plus end-directed myosins (Fig. F-1), (Menetrey et al., 2005).  Tsiavaliaris et 
al. have successfully converted the plus end-directed movement of myosin 1 (MyoE) into 
the opposite direction by attaching protein motifs at the C-terminal end of the neck so 
that the direction of the C-terminal tip is redirected ~180o (Tsiavaliaris et al., 2004).  The 
result strongly supports the lever-arm hypothesis in which the movement directionality 
and the step size of a myosin molecule are determined by the direction and the length of 
the neck. However, it is important to confirm if the minus end-directed movement of 
myosin 6 is simply achieved by the apparently redirected neck.  Identification of myosin 
9b, which does not have such a unique insertion in the neck region, as another minus end-
directed myosin (Inoue et al., 2002) argued against the reversed lever hypothesis, 
although the minus end-directed movement directionality of myosin 9b is controversial 
(O'Connell and Mooseker, 2003). 
In this chapter, a series of chimeric myosin constructs using parts from myosin 5a 
(plus end-directed) and myosin 6 (minu edn-directed) were generated to identify the 
site(s) in a myosin molecule that is responsible for determining the movement 
directionality. 
 
Materials and methods 
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Materials - Nickel-nitrilotriacetic acid agarose (Ni-NTA) was purchased from Qiagen 
(Hilden, Germany).  For other materials, see “Materials and methods” in Chapter II. 
 
Cloning of human myosin 6 - Human kidney total RNA was purchased from Clontech 
(Mountain View, CA), and cDNA library was obtained by reverse transcription with 
random oligonucleotides.  The entire ORF region of myosin 6 (Met 1 – Lys 1285) was 
subcloned in pFastBac vector (for baculovirus expression system) with EcoRI site and 
MluI site at 5’-side and 3’-side, respectively. 
 
Cloning of human myosin 5a - Human brain total RNA was purchased from Clontech 
(Mountain View, CA), and cDNA library was obtained by reverse transcription with 
random oligonucleotides.  A partial ORF region of myosin 5a (Met 1 – Lys 1189) was 
subcloned in pFastBac vector (for baculovirus expression system) with EcoRI site and 
MluI site at 5’-side and 3’-side, respectively. 
 
Construction of myosin 5a–myosin 6 chimera - The myosin consructs were generated by 
two-step PCR method by using human myosin 5a and human myosin 6. (Zarrinpar et al., 
2003) 
 
Baculovirus preparation - See “Materials and methods” in Chapter II. 
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Protein expression and purification - To express the recombinant myosin 5a, myosin 6, 
or myosin 5a – myosin 6 chimeric constructs, Sf9 cells (approximately 8 x 107 cells) were 
co-infected with two viruses expressing the myosin heavy chain and calmodulin.  The 
infected cells were harvested after culturing for three days at 28oC, and washed with a 
buffer containing (150 mM NaCl, 30 mM Tris-HCl, pH 7.5, and 5 mM EGTA).  The 
cells were then lysed by sonication in 4 ml of lysis buffer (100 mM NaCl, 30 mM Tris-
HCl, pH 7.5, 2 mM MgCl2, 0.2 mM EGTA, 1 mM ATP, 1 mM phenylmethyl sulfonyl 
fluoride, 0.1 mg/ml trypsin inhibitor, 10 µg/ml leupeptin, 1 mM 2-mercaptoethanol).  
After centrifugation at 300,000 ×g for 10 min at 4oC, the supernatant was incubated with 
100 µl of Ni-NTA resin in a 5-ml plastic tube on a rotation wheel for 15~20 min at 4oC.  
The resin suspension was then loaded in a column (1 x 10 cm) and washed with 5 ml of a 
wash buffer (300 mM NaCl, 20 mM Tris-HCl, pH 7.5, 10 mM Imidazole-HCl, pH 7.5, 
0.1 mM EGTA, 10 µg/ml leupeptin, and 1 mM 2-mercaptoethanol).  Protein was eluted 
with a buffer containing 100 mM NaCl, 200 mM Imidazole-HCl, pH 7.5, 0.1 mM EGTA, 
5 µg/ml leupeptin, and 1mM 2-mercaptoethanol.  Freshly prepared DTT  (1 mM final 
concentration) was added to the eluted fraction, and stored on ice. 
 
Polarity-marked actin filaments - See “Materials and methods” in Chapter II. 
 
In vitro motility assay - See “Materials and methods” in Chapter II. 
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Results 
 
Myosin 5a and myosin 6 were used for generating chimeric myosin constructs to 
identify the region(s) responsible for directionality determination because of their 
similarity in motor property and opposite movement directionalities. By having ADP 
release step as the predominant rate-limiting step during the ATPase cycle (De La Cruz et 
al., 2001; De La Cruz et al., 1999), both of them are highly processive motors that move 
along actin filaments as dimers in a hand-over-hand mechanism.  The crystal structures of 
the motor domain are now available for both myosin 5a (Coureux et al., 2004) and 
myosin 6 (Menetrey et al., 2005) (Fig. F-1), which enable us to carefully design chimeric 
constructs. 
 
The unique insertion in the neck of myosin 6 
Before the crystal structures of myosin 5a and myosin 6 became available, we 
examined the effect of the unique insertion only found in the neck of myosin 6 by 
generating myosin 5a-myosin6 hybrids.  The result is summarized in Figure F-2 and 
Table F-1.  Contrary to the general expectation, we found that the swapping of the neck 
did not reverse the inherent movement directionality of each myosin, although the actin 
translocating activity was significantly reduced.  Thus, we concluded that the globular 
core domain of myosin determines the movement directionality. 
After the crystal structures of myosin 5a and myosin 6 became available, our 
result on M6M5HMM was reexamined by Park et al. by generating similar chimera using 
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different joining point (Park et al., 2007).  They have successfully converted the minus 
end-directed motility of myosin 6 into plus end-directed motility by replacing the neck 
region with that of myosin 5a.  Since the converter domain and the beginning of the neck 
region reside at the close proximity, replacement of the whole neck region of myosin 6 
with that of myosin 5a may have disrupted an intramolecular interaction of the converter-
neck in our M6M5HMM construct (Fig. F-3).  In order to further examine this issue, we 
generated additional chimeras based on the recently available information from the 
crystal structures. (Fig. F-4).  M6M5conv has the globular motor domain of myosin 6 
followed by the converter and the neck of myosin 5a.  M6M5dPro has the globular motor 
domain and the converter domain of myosin 6 followed by the neck of myosin 5a after 
Asp 773 of myosin 6.  Since the neck of myosin 6 is bent at the proline 774, the 
elimination of the proline residue was expected to extend the neck of M6M5dPro (Fig. F-
3). Both chimeric constructs showed plus end-directed motility (Table F-2), suggesting 
that the minus end-directed movement of myosin 6 is determined by the reorientated neck 
as proposed. 
If the orientation of the neck is the sole determinant of movement directionality, 
the plus end-directed motility of myosin 5a should be converted into the opposite 
direction by introducing the reorientated neck of myosin 6.  However, conversion of the 
plus end-directionality of myosin by using myosin parts has not succeeded yet.  As 
shown in Figure F-2, replacement of the whole converter-neck region of myosin 5a with 
that of myosin 6 did not change the plus end-directionality, implying that the apparently 
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reorientated neck itself is not the sole determinant of the minus end-directed motility of 
myosin 6. 
 
The N-terminal variable region 
The N-terminal region of myosin resides at close proximity of the converter-neck 
region (Fig. F-1), and is highly variable among the superfamily (Fig. F-5).  The lever arm 
hypothesis claims that the conformational change inside the globular motor domain 
induced by the hydrolysis of ATP changes the conformation of the converter domain, 
which allows the lever arm to swing.  Since the neck of myosin 6 is reorientated by ~120o 
relative to plus end-directed myosins, the N-terminal region of myosin 6 might have 
coevolved with the converter-neck region to facilitate the opposite swing of the neck.  
The effect of the N-terminal region on the movement directionality was tested by using 
chimeras shown in Figure F-6, and the result was summarized in Table F-2. Although the 
actin translocating velocities were reduced, the original movement directionalities of 
myosin 5a and myosin 6 were not affected by the deletion of the N-terminal variable 
regions themselves (dM5 and dM6). 
Removal of the N-terminal variable region of myosin 5a (dM5M6) or replacement 
of the variable region with that of myosin 6 (M6M5M6) did not improve the result of the 
M5M6HMM chimera used in our previous study (Fig. F-2 and Table F-1), rather, those 
chimeras lost actin translocating activity.  Removal of the N-terminal variable region of 
myosin 6 (dM6M5) or replacement with that of myosin 5a (M5M6M5) did not change 
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the result on M6M5conv, suggesting that the N-terminal variable region of myosin has 
little effect on the determination of the movement directionality. 
The contribution of the N-terminal region to movement directionality was further 
examined by using additional chimeras shown in Figure F-7. Although the M5M6M5LP 
chimeras showed comparable actin translocating velocities to M6M5conv chimeras, 
M6M5M6LP did not show any motility (Table F-2). 
Altogether, the results suggest that the N-terminal region of myosin is not 
important for deciding the movement directionality.  The effect of the N-terminal region 
of myosin was not pursued further. 
 
The relay helix 
The relay helix translocates in response to the conformational change inside the 
core of the motor domain induced by ATP hydrolysis (Fig. F-8).  This conformational 
change is responsible for the increase in the fluorescence of the relatively conserved 
tryptophan residue at the tip of the relay helix.  It has been proposed that this 
translocation of the relay helix changes the conformation of the converter domain, thus 
allowing the neck to swing (Fig. F-8).  The primary structure of the relay helix and the 
converter region are relatively conserved among myosins, and the apparent positioning of 
those regions in the crystal structure of myosin 6 looks similar to other myosins (Fig. F-
1).  However, it may be possible that a subtle difference in the relay helix-converter 
interaction is essential for the reorientated lever arm to swing backward.  To test this 
possibility, we generated a series of chimeric myosin constructs shown in Figure F-9.  
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Although the actin translocating velocities of M5relay and M6relay were reduced, 
replacement of the relay helix itself did not affect the plus end-directed motility of 
myosin 5a and the minus end-directed motility of myosin6 (Table F-2).  Replacement of 
the relay helix region of M5M6conv with that of myosin 6 (M5M6relay) did not confer 
minus end-directed motility to the construct, either.  Likewise, replacement of the relay 
helix region of M6M5conv with that of myosin 5a (M6M5relay) did not rescue the slow, 
plus end-directed actin translocation of the M6M5conv construct.  These results suggest 
that the relay helix-converter interaction of myosin 6 is not uniquely adjusted for the 
minus end-directed motility. 
 
The small insertion in the motor domain 
Besides the insertion in the neck, myosin 6 has another small insertion at the 
vicinity of the ATP binding site (Fig. F-5 and Fig. F-10).  The small insertion is 
responsible for the very slow second-order ATP binding rate of myosin 6 (Menetrey et 
al., 2005).  The deletion of the insertion not only increases the second-order ATP binding 
rate, but also increases the maximum ATPase activity of myosin 6 by increasing the ADP 
release rate ~3-fold (Menetrey et al., 2005).  Recently, this small insertion has been found 
to be important for coordination of the two heads of myosin 6 for the processive 
movement – deletion of the insert abolishes the processibly of myosin 6 (Sweeney et al., 
2007).  We generated a myosin 6 construct in which small insertion region was replaced 
with the comparable region of myosin 5a (Fig. F-10).  This chimera (M6ins5) showed ~3-
fold increase in actin translocating velocity that is consistent with the ~3-fold increment 
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of the ATPase activity reported previously (Menetrey et al., 2005). However, the 
movement directionality did not change.  Similarly, introducing the small insertion of 
myosin 6 to M5M6conv did not confer minus end-directed motility on the construct (Fig. 
F-10B and Table F-2).  These results suggest that the small insertion in the motor domain 
of myosin 6 is not essential for the minus end-directed motility. 
 
Discussion 
 
 In this chapter, a number of hybrid myosin constructs were generated and their 
movement directionalities were tested to identify the region(s) inside the myosin 
molecule that is responsible for determining the movement directionality.  Because we 
were not able to identify the exact region(s) responsible for determining the 
directionality, a possible molecular mechanism behind the directionality is discussed by 
referring to some advanced studies on kinesin motors. 
Kinesin and its related protein, non-claret disjunctional (Ncd) protein, are 
microtubule-based molecular motors that move along a microtubule towards plus end and 
minus end, respectively.  Kinesin and Ncd have very similar motor core structures to 
those of myosins (Fig. F-11), implying that they share similar ATP-driven motor 
mechanism.  The motor core domain of Ncd directly interacts with the distal end of the 
stalk, and the motor core region is relatively immobilized against the stalk (Sablin et al., 
1998).  Unlike Ncd, the motor core domain of kinesin does not directly interact with the 
stalk because of a linker region that joins the motor core and the stalk.  This so-called 
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‘neck linker’ region comprised of ~15 amino acids was proposed to be important for the 
efficient unidirectional processive movement of kinesin. The neck regions of kinesin and 
Ncd have been identified to be responsible for dictating the movement directionality. 
Fusing the neck and stalk of kinesin (plus end-directed) to the motor core of Ncd (minus 
end-directed) generated a plus end-directed motor (Case et al., 1997; Henningsen and 
Schliwa, 1997), whereas fusing the neck and stalk from Ncd to the motor core of kinesin 
generated a minus end-directed motor (Endow and Waligora, 1998).  These neck regions 
of kinesin and Ncd roughly correspond to the converter region of myosins (Fig. F-11), 
and the neck linker region of kinesin is often compared to the lever arm of myosin.  
Remarkably, however, disruption of the structure of the neck linker did not affect the plus 
end-directed motility of kinesin (Case et al., 2000; Inoue et al., 1997; Sablin et al., 1998).  
Also interestingly, the minus end-directed motility of Ncd is easily reversed by a single 
or double point mutation in the neck without swapping the whole neck/stalk region 
(Endow and Higuchi, 2000; Endow and Waligora, 1998).  These results suggest that the 
neck region is not required for defining the plus end-directed motility, and that the plus 
end-directed motility is an intrinsic nature of the motor core domain of kinesin and Ncd. 
The directionality of myosin is reminiscent of the directionality of kinesin and 
Ncd - the minus end-directed motility of myosin 6 was easily reversed, implying that the 
motor core of myosin inherently has plus end-directed motility.  The minus end-directed 
motility of myosin 6 has been successfully converted into the plus end-directed motility 
by swapping the redirected neck with the straight neck of myosin 5a or replacing the 
whole converter-neck region with that of myosin 5a.  Likewise, the plus end-directed 
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motility of myosin 1 (MyoE) has been successfully converted into minus end-directed 
movement by attaching artificial protein motifs at the C-terminal end of the neck so that 
the direction of the C-terminal tip is redirected ~180o (Tsiavaliaris et al., 2004).  These 
results seem to strongly support the idea that the ~120o redirected neck of myosin 6 is 
responsible for the reversed directionality by changing the direction of the swing of the 
lever arm.  Although the idea seems to be reasonable based on the lever arm hypothesis, 
there are at least two inexplicable issues.  First, it cannot explain the minus end-directed 
motility of myosin 9b.  The neck region of myosin 9b does not seem to be bent because it 
does not contain an insertion found in the neck region of myosin 6 (Fig F-5).  Second, the 
plus end-directed motility of myosin 5a failed to be converted by introducing the 
converter-neck region of myosin 6 (M5M6, M5M6conv, M5M6SH, dM5M6, M6M5M6, 
M6M5M6LP).  The apparent negative results can be simply explained by the disruption 
of the proper intramolecular interactions by force-connecting different myosin parts. 
However, this is less likely for some chimeras (M5M6conv, dM5M6, M6M5M6, 
M6M5M6LP) because their complementary chimeric constructs (M6M5conv, dM6M5, 
M5M6M5, M5M6M5LP) all showed reproducible plus end-directed motility despite their 
slower actin translocation rates. 
The globular motor cores of myosin 6 and myosin 5a are similar, and dimeric 
myosin 6 and myosin 5a have similar average step size when they move along actin 
filaments (~36nm). However, the step size distribution of myosin 6 is much wider than 
that of myosin 5a.  Since the predicted coiled-coil region of myosin 6 does not form 
stable coiled-coil, the broad step size distribution has been thought to be a result of zip-
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unzip transition of the coiled-coil.  However, Park et al. reported recently that even if the 
neck and the coiled-coil of myosin 6 were replaced with the neck and the stable coiled-
coil of myosin 5a, the broad step size distribution was not affected (Park et al., 2007).  
This result strongly suggests that the intrinsic motor property of myosin 6 is evidently 
different from that of myosin 5a. 
We propose that there is an alternative or an additional structural element(s) in the 
globular motor domain that defines the minus end-directed motility of myosin 6.  
Unfortunately, we were unable to identify the region in the current study.  At least, the N-
terminal variable region, the relay helix, and the small insertion in the vicinity of the ATP 
binding site of myosin 6 are not essential for defining the minus end-directed motility.  
The other possible region not tested at this point is the loop 2 region.  Loop 2 is involved 
in one of the actin binding sites of myosin, and is highly variable among the myosin 
superfamily (Fig. F-5).  As mentioned in Chapter VI, myosin 9 contains an extremely 
large insertion in this loop, and its movement directionality cannot be explained by the 
apparent structure of the neck region.  It would be interesting to see if the loop-2 region is 
essential for deciding the movement directionality of myosin motors. 
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Figure F-1. Myosin crystal structures. Only the motor domains and their first light 
chains (colored in pale yellow or light orange) are shown. The heavy chains are colored 
in green, blue, and red, from the N-terminus to the C-terminus. A, Class 2 myosin 
(1DFK). B, Class 5 myosin (1OE9), C, Class 6 myosin (2BKH). 
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Figure F-2. Structure of the hybrid myosin constructs. a, Schematic representation of 
indicated myosin constructs. M5HMM consists of the two complete heads of myosin 5a 
(motor domain + six IQ motifs) plus the entire coiled-coil domain of myosin 5a. 
M6HMM consists of the two complete heads of myosin 6 (motor domain + myosin 6-
specific large insert + one IQ motif) plus the entire coiled-coil domain of myosin 6. 
M5M6HMM is composed of two heads (containing the motor domain and converter 
domain of myosin 5a and the myosin 6 specific large insert + myosin 6 IQ motif) plus the 
entire coiled-coil domain of myosin 6. M5M6CVHMM substitutes the converter domain 
of M5M6HMM with the myosin 6 converter domain. M5M6SHCVHMM substitutes the 
SH1/SH2 helix and converter domain of M5M6HMM with its myosin 6 counterpart. 
M6M5HMM is composed of two heads (containing the motor domain and converter 
domain of myosin 6 connected with the six myosin 5a IQ motifs, but without the large 
myosin 6-specific insert) plus the entire coiled-coil domain of myosin 5a. b, Primary 
structure of various myosin constructs. Myosin 5a (blue) and myosin 6 (green) sequences 
are indicated. Red box, IQ motif; checkered box, myosin 6-specific large insertion 
between the converter and IQ domain; solid bar, the motor core. 
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Figure F-3. The converter-neck region of myosin 6. The SH helix and the converter 
domain are shown in purple, and the neck is shown in red. Amino acid residues at the 
interface of the converter and the root of the neck are shown with spheres. The green 
sphere indicates the conserved glycine residue that was used as the joining point of 
myosin 5a and myosin 6 in our previous study (M5M6HMM and M6M5HMM in Figure 
F-2). The yellow sphere indicates the proline residue, which seems to be important for 
redirecting the neck. 
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Figure F-4. M6M5conv and M6M5dPro chimeras. A, The expected overall structures 
of the motor domain of the chimeras are shown using the crystal structure of myosin 5a. 
Red and blue colors indicate contribution from myosin 6 and myosin 5a, respectively. 
The light chain is shown in light orange. B, Schematic representation of M6M5conv and 
M6M5dPro constructs. Human myosin 6 and myosin 5a are used for generating these 
chimeras. A myc epitope tag and an octahistidine tag were attached at the C-terminal end 
of each construct for facilitating protein purification and the following ensemble in vitro 
motility assay. 
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IGVLDIAGFEYFEHNSFEQFCINYCNEKLQQFFNERILKEEQELYQKEGLGVNEVHYVDNQDCIDLIEAKLVGILDILDEENRLPQPSDQHFTSAVHQKHKDHFRLTIPRKSKLAVHRNIRDDEG
IGLLDIFGFENFAVNSFEQLCINFANEHLQQFFVRHVFKLEQEEYDLESIDWLHIEFTDNQDALDMIANKPMNIISLIDEESKFPKGTDTTMLHKLNSQHKLNANYIPPKNNHETQ
IGVLDIFGFEDYENNSFEQFCINFANERLQHYFNQHIFKLEQEEYRTEGISWHNIDYIDNTCCINLISKKPTGLLHLLDEESNFPQATNQTLLDKFKHQHEDNSYIEFPAVMEPA
IGVLDIFGFEDFERNSFEQFCINYANEQLQYYFNQHIFKLEQEEYQGEGITWHNIGYTDNVGCIHLISKKPTGLFYLLDEESNFPHATSQTLLAKFKQQHEDNKYFLGTPVMEPA
IGILDIFGFENFEVNHFEQFNINYANEKLQEYFNKHIFSLEQLEYSREGLVWEDIDWIDNGECLDLIEKKL-GLLALINEESHFPQATDSTLLEKLHSQHANNHFYVKPRVAVNN
IGVLDIAGFEIFDFNSFEQLCINYTNERLQQFFNHHMFILEQEEYKKEGIAWEFIDFGMDLQMCIDLIEKPMGILSILEEECMFPKADDKSFQDKLYQNHMGKNRMFTKPGKPTRPNQGPAH
GKTKIFIRSPKTLFYLEEQRRLRLQQLATLIQKIYRGWRCRTHYQLMRKSQILISSWFRGNMQKKCYGKIKASVLLIQAFVRGWKARKNYRKYFRSEAALTLADF----
GHTKVFFKAGLLGLLEEMRDEKLAQLITRTQAMCRGFLARVEYQKMVERRESIFCIQYNVRAFMNVKHWPWMKLYFKIKPLLKSAE----
GKTKVFLKYYHVEQLNLMRKEAIDKLILIQACVRAFLCSRRYQKIQEKRKESAIIIQSAARGHLVGKQRKEIVDMKNTAVTTIQTSDQE----
GKTKIFFRAGQVAYLEKLRADKLRAACIRIQKTIRGWLLRKKYLRMRKAAITMQRYVRGYQARCYAKFLRRTKAATIIQKYWRMYVVRRRYKIRRAATIVLQSYLRGFLARNRYRKILRGHKAVIIQKRVRGWLARTHYKRSMHAIIYLQCCFRRMMAKRELKKLKIEARSVE---
GLTKVFFRPGKFAEFDQIMKSDPDHLAELVKRVNHWLTCSRWKKVQWCSLSVIKLKNKIKYRAEACIKMQKTIRMWLCKRRHKPRIDGLVKV---
GKTKIFLKDHHDMLLEVERDKAITDRVILLQKVIRGFKDRSNFLKLKNAATLIQRHWRGHNCRKNYGLMRLGFLRLQALHRSRKLHQQYRLARQRIIQFQARCRAYLVRKAFRHRLWAVLTVQAYARGMIARRLHQRLRAEYLWRLE---
GKTMVFLKEQERQHLQDLLHQEVLRRIILLQRWFRVLLCRQHFLHLRQASVIIQRFWRNYLNQKQVRDAAVQKDAFVMASAAALLQASWRAHLERQRYLELRAAAIVIQQKWRDYYRRRHMAAICIQAR---
GKTKVFLKETERQALQETLHREVVRKILLLQSWFRMVLERRHFLQMKRAAVTIQACWRSYRVRRALERTQAAVYLQASWRGYWQRKLYRHQKQSIIRLQSLCRGHLQRKSFSQMISE---
GKTKVFLRESLEQKLEKRREEEVSHAAMVIRAHVLGFLARKQYRKVLYCVVIIQKNYRAFLLRRRFLHLKKAAIVFQKQLRGQIARRVYRQLLAEKREQ---
GTTKVFFKAGVLGNLEEMRDERLSKIISMFQAHIRGYLIRKAYKKLQDQRIGLSVIQRNIRKWLVLRNWQWWKLYSKVKPLLSIARQEE---
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Figure F-5. Sequence alignment of myosins from class 1, 2, 3, 5, 6, 7, 9, and 10.  The 
amino acid sequences of the N-terminal motor domain and the neck are shown. Highly 
conserved amino acids are shown in magenta. 
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Figure F-6. dM5, dM6M5, M5M6M5, dM6, dM5M6, and M6M5M6 chimeras. A, 
The expected overall structures of the motor domain of the chimeras are shown using the 
crystal structure of myosin 6 and myosin 5a. Red and blue colors indicate contribution 
from myosin 6 and myosin 5a, respectively. The light chain is shown in light orange. B, 
Schematic representation of dM5, dM6M5, M5M6M5, dM6, dM5M6, and M6M5M6 
constructs. Human myosin 6 and myosin 5a are used for generating these chimeras. A 
myc epitope tag and an octahistidine tag were attached at the C-terminal end of each 
construct for facilitating protein purification. 
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Figure F-7. M5M6M5LP and M6M5M6LP chimeras. A, The expected overall 
structures of the motor domain of the chimeras are shown using the crystal structure of 
myosin 6 and myosin 5a. Red and blue colors indicate contribution from myosin 6 and 
myosin 5a, respectively. The light chain is shown in light orange. B, Schematic 
representation of M5M6M5LP and M6M5M6LP constructs. Human myosin 6 and 
myosin 5a are used for generating these chimeras. A myc epitope tag and an octahistidine 
tag were attached at the C-terminal end of each construct for facilitating protein 
purification. 
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Figure F-8. Conformational change of myosin induced by the ATP hydrolysis. Two 
crystal structures of scallop myosin 2 (Houdusse et al., 2000) are shown. The relay helix 
is colored in red. The converter and the neck region are colored in magenta. The 
relatively conserved tryptophan residue at the tip of the relay helix is shown in orange 
with sphere. The apparent swing-like conformation change of the neck seems to be linked 
to the translocation of the relay helix induced by the hydrolysis of ATP. 
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Figure F-9. M5relay, M6relay, M5M6relay, and M6M5relay chimeras. A, The 
expected overall structures of the motor domain of the chimeras are shown using the 
crystal structure of myosin 6 and myosin 5a. Red and blue colors indicate contribution 
from myosin 6 and myosin 5a, respectively. The light chain is shown in light orange. B, 
Schematic representation of M5relay, M6relay, M5M6relay, and M6M5relay constructs. 
Human myosin 6 and myosin 5a are used for generating these chimeras. A myc epitope 
tag and an octahistidine tag were attached at the C-terminal end of each construct for 
facilitating protein purification. 
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Figure F-10. The small insertion in the vicinity of the ATP binding site of myosin 6. 
A, The crystal structures of the motor domain of myosin 5a and myosin 6 are shown. The 
heavy chains of myosin 5a and myosin 6 are colored in blue and red, respectively. Their 
light chains are shown in light orange. The unique small insertion of myosin 6 and the 
corresponding site in myosin 5a are highlighted in magenta. B, Schematic representation 
of M6ins5 and M5M6ins6 constructs. Red and blue colors indicate contribution from 
myosin 6 and myosin 5a, respectively. Human myosin 6 and myosin 5a are used for 
generating these chimeras. A myc epitope tag and an octahistidine tag were attached at 
the C-terminal end of each construct for facilitating protein purification and the following 
ensemble in vitro motility assay. 
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Figure F-11. The crystal structures of myosin 5a, kinesin, and Ncd. The regions 
containing P-loop, switch I, and switch II/relay helix are colored in magenta, cyan, and 
orange, respectively. The converter region and the neck linker region are colored in blue. 
The neck regions are colored in red. A, The crystal structure of myosin 5a (1OE9). B, 
The crystal structure of kinesin (1MKJ). C, The crystal structure of Ncd (2NCD). 
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